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ABSTRACT 
 
Salmonella enterica subsp. enterica serovar 4,[5],12:i:- is widely accepted to be a 
monophasic variant of Salmonella Typhimurium. Salmonella 4,[5],12:i:- has been increasing 
significantly in prevalence worldwide over the past decade while S. Typhimurium has been 
subsequently decreasing. Both Salmonella serovars 4,[5],12:i:- and  Typhimurium are contained 
in Salmonella serogroup B, which is currently the predominant serogroup in swine in the United 
States. However, this serogroup contains serovars of a wide range of pathogenic potential, with 
Typhimurium generally being associated with enterocolitis and Agona and Derby generally 
being considered to be of lesser pathogenicity. The pathogenic potential for S. 4,[5],12:i:- in 
swine is largely unknown but is hypothesized to be similar to S. Typhimurium based on genetic 
similarities. Current diagnostic procedures for the detection and identification of Salmonella 
have a wide range of sensitivities, and culture-based protocols have a prolonged turn-around time 
to serovar-level identification due to the complex serotyping process. To facilitate more rapid 
detection and serovar-level identification, the work conducted within this thesis validated a 
multiplex real-time PCR capable of detecting Salmonella spp. in general and differentiating S. 
4,[5],12:i:- and S. Typhimurium from other lesser-pathogenic serovars. Further work was 
focused on determining the level of clinical disease, colonization of tissues, and persistence of 
infections to be expected with the S. 4,[5],12:i:- in swine. For this study, pigs were 
experimentally infected with S. 4,[5],12:i:-, S. Typhimurium, or S. Derby to compare S. 
4,[5],12:i:- to the pathogenic S. Typhimurium and less-pathogenic S. Derby. This work 
demonstrated that S. 4,[5],12:i:- induces similar levels of clinical disease, tissue colonization, and 
persistent infections to that of S. Typhimurium, both of which were more severe than that of S. 
v 
Derby. Simultaneous infection of swine with equal amounts of S. 4,[5],12:i:- and S. 
Typhimurium revealed S. 4,[5],12:i:- is detected in higher levels in the feces, tonsils and 
ileocecal lymph nodes than S. Typhimurium, indicating a potential increased competitive fitness 
of the monophasic variant. The collective results of these studies provide improved diagnostics 
and needed insight into the disease causing ability of an increasingly prevalent serovar of 
Salmonella that is capable of infecting swine, humans, and other species.
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CHAPTER 1: 
GENERAL INTRODUCTION 
 
Specific Aims and Significance 
Salmonella 4,[5],12:i:- is considered a monophasic variant of Salmonella Typhimurium. 
However, even with the increasing prevalence of the monophasic serovar, much remains 
unknown regarding its potential as a pathogen of swine. Therefore, the goal of this work was to 
characterize Salmonella 4,[5],12:i:- as a pathogen of swine and validate rapid testing methods for 
S. 4,[5],12:i:- and S. Typhimurium. We hypothesized that S. 4,[5],12:i:- is a primary pathogen of 
swine similar to that of S. Typhimurium and has a greater fitness within the swine host. To test 
this hypothesis, four specific aims were developed: 1) document the prevalence of S. 4,[5],12:i:- 
in swine; 2) validate a multiplex real-time PCR to facilitate the rapid detection of Salmonella and 
differentiation of S. 4,[5],12:i:- and S. Typhimurium from other serovar of potentially lesser-
pathogenicity; 3) characterize the disease, tissue colonization, and persistence of Salmonella 
4,[5],12:i:- relative to better known serovars; and 4) evaluate the competitive fitness of S. 
4,[5],12:i:- and S. Typhimurium following simultaneous inoculation of swine with both serovars.  
 
Organization of Thesis 
This thesis is organized in three chapters. The first chapter includes a literature review of 
pertinent peer reviewed studies related to the genus of Salmonella and the serovar Salmonella 
4,[5],12:i:-. The second chapter describes the changes in prevalence of relevant serovars of 
Salmonella in swine and the validation of a real time PCR to facilitate rapid detection and 
identification of Salmonella 4,[5],12:i:- and Typhimurium. The third chapter describes three in 
vivo studies of swine conducted to evaluate the pathogenicity and competitive fitness of 
Salmonella 4,[5],12:i:- relative to other serovars of Salmonella.  
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Literature Review 
General information on the Salmonella genus 
The Salmonella genus is in the Enterobacteriaceae family, a family comprised of gram 
negative rods that are facultative anaerobes, non-spore forming, motile, catalase positive, and 
oxidase negative1,2. The Salmonella genus contains very resilient bacteria, making them able to 
survive in a variety of environments, including pH ranging from 4.0 to 9.5 and temperatures 
ranging from 8˚C to 45˚C1. Depending on the specific serovar and isolate, the survivability in the 
environment may extend outside of the listed ranges1. This hardiness facilitates its persistence in 
the environment, in livestock feed, and in human food. Salmonellosis (colonization of a 
Salmonella species in a host) occurs via the transmission of bacteria through the fecal-oral 
route1,3,4. The focus of this review will be on salmonellosis in swine and the impact on human 
health, although infections of other species will be mentioned briefly. Additionally, the focus 
will be placed on the newly emerging serovar, Salmonella enterica subspecies enterica serovar 
4,[5],12:i:-.  
 
Nomenclature and serotyping of Salmonella  
The nomenclature system for the Salmonella genus contains many components. Starting 
with the species level, identified by genetic relation and biochemical testing, there are two 
species, bongori and enterica1,5. The species are then divided into subspecies based on 
biochemical testing, normal habitat, and genetic relation; species enterica includes subspecies I, 
II, IIIa, IIIb, IV, and VI while species bongori contains subspecies V1,5. Salmonella enterica 
subspecies I, also known as subspecies enterica, causes the majority of the Salmonella infections 
in warm blooded animals and humans1 and will therefore be the focus of this paper. Subspecies 
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are then broken down into serogroups, which is based on the somatic, or “O”, antigen. The most 
common serogroups involved in infections of warm blooded animals and humans are A, B, C1, 
C2, D, and E, although additional serogroups exist5. While identification of the serogroup is 
beneficial in gaining a better understanding of the potential pathogenicity of an isolate, it still 
leaves a wide range of potential serovars. The serogroups are divided into serovars (serotypes) 
based on their flagellar, or “H”, antigens5. There are over 2,500 serovars with more being 
discovered to this day6. Serovars vary greatly in their pathogenicity, host range, and other 
characteristics. For example, within serogroup B are serovars Typhimurium, Agona, Derby, and 
Heidelberg. In a comparison of histologic lesions in swine associated with each of these serovars, 
94% of samples from which Salmonella Typhimurium was isolated had lesions consistent with 
salmonellosis; this is in contrast to just 31% of samples from which Salmonella Agona, 
Salmonella Derby, or Salmonella Heidelberg were isolated that had salmonellosis-suggestive 
lesions7. Overall, Salmonella naming should be as follows: “Salmonella (species) subsp. 
(subspecies) (Serovar)”. The serovar is named starting with the O antigens, then phase 1 flagellar 
antigens, and finally phase 2 flagellar antigens, all separated by colons5. For example, the 
common name of Salmonella Typhimurium, a serovar with potential to cause disease in all 
species, is actually Salmonella enterica subsp. enterica serovar 4,[5],12:i:1,2.  
The conventional method for determining the serovar involves agglutination testing with 
multiple antisera targeting the somatic and flagellar antigens to identify the phenotypic 
characteristics, a process known as the Kauffmann-White-Le Minor Scheme8. In the United 
States as a part of the national surveillance program, the Kauffmann-White-Le Minor scheme is 
the chosen method for serotyping isolates from human specimens6. The challenge associated 
with this method revolves around the 64 potential O variants and 114 potential H variants, 
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thereby requiring a massive amount of antisera to maintain the ability to characterize all 
serovars8. More recently, other serotyping methods have evolved that focus more on the genetic 
rather than phenotypic characteristics, including pulsed field gel electrophoresis (PFGE), 
molecular serotyping by detection of the genes encoding the O and H antigens, and whole 
genome sequencing to name just a few8. Regardless of the method used to further characterize 
Salmonella isolates, identification at the serovar level is necessary to facilitate appropriate 
responses to the infection and to enable epidemiological studies.  
 
Risk of salmonellosis to swine 
Infections with Salmonella in swine, termed salmonellosis, are most common in weaned 
pigs approximately 6-12 weeks of age, but older and younger pigs can be infected in certain 
situations4. Morbidity, mortality, and clinical presentation of infection varies with the infecting 
serovar, age of pigs, and immunity possessed by the pigs4. Infection may present as either 
septicemia, which is more common with Salmonella Choleraesuis, or enterocolitis, which is 
more common with serovars such as Salmonella Typhimurium4. In the septicemic form, pigs 
become anorexic, lethargic, febrile, and dyspneic4. The enterocolitic form is generally associated 
with diarrhea, anorexia, lethargy, and fever4. The mortality of the septicemic form is typically 
higher than with the enterocolitic form while the opposite is often true for the morbidity of the 
two forms4. Gross lesions of both forms can include ulcerative and necrotic colitis and typhlitis, 
enlarged mesenteric lymph nodes, enlarged spleen and liver, and lung congestion4. The 
mandibular lymph nodes can be infected with Salmonella due to the oral route of infection, but 
they often appear normal grossly9. The variability in salmonellosis clinical signs, gross lesions, 
and distribution in the body complicates diagnosis of infection. 
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One of the more common and important forms of salmonellosis in swine is the 
asymptomatic infection. In this form, pigs shed Salmonella in their feces even though they lack 
clinical signs of disease10. While the pigs with subclinical salmonellosis do not have overt 
clinical disease, they do tend to be less productive than their uninfected counterparts as 
evidenced by a reduced average daily gain in pigs shedding higher levels of Salmonella in their 
feces11. The asymptomatic form is unfortunately complicated by the extensive and unpredictable 
variation in shedding patterns based on individual factors, environment, and Salmonella-strain 
specific factors. In one study, the shedding of Salmonella from naturally-infected pigs was 
followed from 10 weeks of age to the time of slaughter at 22 weeks of age10. The number of 
weeks in which the pigs were shedding ranged from just one week out of the 12-week period to 
nine weeks out of 1210. Even among those that shed Salmonella for the same amount of weeks, 
the specific weeks in which they were shedding varied by individual10. The variations in 
shedding made it clear that samples tested for Salmonella in the late finishing stage are not 
always an accurate reflection of the true Salmonella status of the animal tested as they may have 
not been shedding in the week or two prior to slaughter despite the continued presence of 
Salmonella in their system10.  
There is also some effect of serovar on the duration and pattern of shedding, but this 
needs explored further10. This variation emphasizes the need for rapid and accurate diagnostics 
on repeated samples from pigs to facilitate appropriate treatment prior to entering the slaughter 
facility. Others have examined the effect of dose and serovar on the shedding pattern of 
Salmonella12. The effect of the infecting dose appeared to be a more important factor than the 
serovar of the challenge when determining the level of shedding12. Swine infected with the same 
doses of Salmonella Yoruba, a generally non-pathogenic serovar found in feed, and Salmonella 
6 
 
 
Typhimurium, a classic pathogenic serovar of swine, shed Salmonella for a similar amount of 
time in their feces12. On the other hand, swine infected with 103 CFU and 106 CFU shed 
Salmonella for a significantly reduced duration when compared to those infected with 109 CFU, 
regardless of whether the pigs were infected with Salmonella Yoruba or Salmonella 
Typhimurium12.  
Salmonella, no matter the form of clinical disease, can colonize various tissues in an 
infected pig. These tissues can include but are not limited to the ileum and other parts of the 
intestinal tract, ileocecal lymph nodes, tonsils, and mandibular lymph nodes9. In randomly 
selected swine in a slaughter facility, the ileocecal lymph nodes were found positive for 
Salmonella 18.8% of the time, while 13.9% of ileal samples, 12.9% of mandibular lymph node 
samples, and 9.9% of tonsillar samples were positive for Salmonella9. Thirteen of 101 (12.9%) 
carcasses were positive for Salmonella, but 30% of those carcasses did not have a positive tissue 
sample from the corresponding pig which indicates the presence of cross-contamination between 
carcasses9. This underscores the added risk that infected animals present both from the initially 
infected carcass and the contamination of nearby carcasses in the slaughter facility9. The risk of 
Salmonella contamination must be reduced by starting at the farm level to decrease the 
occurrence of Salmonella-positive pigs entering slaughter facilities, which requires accurate and 
rapid diagnostic procedures.  
 
Risk of salmonellosis to humans 
The economic impact of reduced productivity and treatment costs in pigs with 
salmonellosis as well as the health impact of infections of swine and humans highlights the need 
to control Salmonella and eliminate the organism whenever possible. Non-typhoidal Salmonella 
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causes more than 1.2 million human illnesses worldwide and 100,000 human illnesses in the 
United States every year13; of these illnesses in the United States, approximately 40 deaths occur 
each year14. Salmonella is not the leading cause of foodborne illnesses, but it is still of primary 
concern given that it is the leading cause of foodborne illness-related hospitalizations and deaths 
in the United States15,16. Younger individuals, especially infants, tend to have the highest 
incidence of Salmonella infections17,18.  
Salmonella Typhimurium has commonly been implicated as a cause of food-borne illness 
in humans for many years. There was an outbreak reported in the United States in 2010 
associated with pork19, another outbreak in Denmark in 2011 associated with pork19,20, and yet 
another outbreak in 2005 in Australia associated with lamb liver21. However, an increasing 
number of foodborne outbreaks of Salmonella 4,[5],12:i:- have also been reported in the recent 
years. Most commonly, these outbreaks are the result of Salmonella 4,[5],12:i:- contamination of 
pork products22. Specifically, one outbreak in France in 2011 was the result of contamination of 
pork, although the evaluation of raw materials and the food products did not test positive for 
Salmonella22. Another outbreak was reported in 2010 in France associated with beef 
consumption23. Yet another outbreak was reported in 2015 in the United States associated with 
pork consumption24. 
 
Prevalence by Salmonella serovar 
In humans in the United States, the top five serovars in 2015 in order of most commonly 
involved in humans infections to least were Enteritidis, Typhimurium, Newport, Javiana, and 
4,[5],12:i:-18. However, the prevalence of each serovar in any given host species does not remain 
static from year to year. For example, Salmonella Typhimurium has decreased in prevalence 
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from 2005-2015, for a total change of -26.2%18. On the other hand, Salmonella 4,[5],12:i:- has 
done the opposite and increased in prevalence from 2005-2015, for a total change of +194.2%18. 
Additionally, Salmonella 4,[5],12:i:- has increased in rank of serovar prevalence in human 
infections from 8th in 2005 to 5th in 201518. It would be expected based on trends in livestock that 
the prevalence and rank of Salmonella 4,[5],12:i:- in human infections will continue to increase 
from 2015 to present.  
Interestingly, Salmonella 4,[5],12:i:- was rarely reported prior to the 1990’s25. The 
earliest report of the serovar was in 1946 when three isolates of Salmonella 4,[5],12:i:-, although 
identified as abnormal Salmonella Typhimurium at the time, were discovered as they failed to 
react in anti-i serum26. Between the under-reporting that likely occurs with salmonellosis in 
general and the potential misclassification of Salmonella 4,[5],12:i:-25, it is difficult to determine 
exactly when Salmonella 4,[5],12:i:- actually emerged. What is clear is that in the past 10-15 
years, there has been an increase in prevalence and recognition of Salmonella 4,[5],12:i:-.  
In the European Union, a trend similar to that in the United States has been observed17. In 
order of most commonly involved in humans infections to least in Europe in 2016 were 
Enteritidis, Typhimurium, 4,[5],12:i:-, Infantis, and Newport17. Salmonella Typhimurium has 
been also been decreasing in prevalence in the EU since 2014 while 4,[5],12:i:- has been 
increasing although at a slower rate than that observed in the United States17. Based on zoonoses 
and food-borne outbreaks in 2016 in the European Union, interestingly, different livestock 
species contribute different serovars to humans infections17. Swine in the EU primarily 
contribute Salmonella Typhimurium and Salmonella 4,[5],12:i:- to human infections while cattle 
contribute Salmonella Typhimurium predominantly17. In contrast to the previously mentioned 
prevalence reports, in cases from 2001-2007 reported by national surveillance programs in the 
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European Union and United States, the World Health Organization (WHO) revealed that the top 
20 most common serovars in humans in the European Union, Africa, Australia, and New 
Zealand did not include Salmonella 4,[5],12:i:-27. Salmonella 4,[5],12:i:- was likely not among 
the most prevalent serovars at this time because this study pre-dates the rapid increase of 
identification observed in Salmonella 4,[5],12:i:- over the last decade.  
 In humans in China from 2009-2010, Salmonella Typhimurium remained the most 
prevalent isolate, comprising 45.2% of the isolates, while Salmonella Enteritidis, Salmonella 
Stanley, and Salmonella 4,[5],12:i:- trailed behind with 12.5%, 7.1%, and 4.5% respectively28. 
Changes have likely occurred in the distribution of serovars since this study was conducted 
nearly a decade ago. From 2007-2011 in Switzerland, the prevalence of Salmonella 4,[5],12:i:- 
changed significantly, from making up just 5.8% of the Salmonella isolates from humans in 2007 
to 18.2% in 201129. It is important to keep in mind that the prevalence of serovars clearly varies 
by geographic location, but with all of the travel and trade that occur throughout the world 
pathogens have the potential to spread rapidly across national borders27.  
In swine, just like in humans, the common serovars vary based on geographic location. 
Based on samples submitted to the Minnesota Veterinary Diagnostic Laboratory (VDL) in 2014, 
swine were most commonly infected with, in order of highest to lowest prevalence: Agona, 
Typhimurium var 5- (Copenhagen), 4,[5],12:i:-, Derby, and Typhimurium30. Salmonella 
4,[5],12:i:-, Agona, and Typhimurium all increased in prevalence from 2013-2014 while the 
remaining two serovars decreased in prevalence30. The data from the Minnesota VDL separated 
Salmonella Typhimurium and Salmonella Typhimurium var 5- into two serovar groups; 
however, there have not been any reports of differences in var 5+ and var 5- strains with respect 
to their disease-causing ability and are kept in the same serovar group in all other data sets. 
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Based on samples submitted to the Iowa State University VDL (ISU-VDL) from 2003-2015, the 
proportion of Salmonella serovars Typhimurium, Derby, and Heidelberg have all decreased, in 
contrast to serovars 4,[5],12:i:-, Infantis, and Johannesburg which have all increased31. The most 
dramatic increase was observed with Salmonella 4,[5],12:i:-, though, from 0% in 2003 to 30% of 
the swine Salmonella isolates in 201531.  
In a study examining pigs in a slaughter facility in Portugal from 2003-2004, the serovars 
with the highest prevalence were Typhimurium and Rissen9. Salmonella 4,[5],12:i:- was isolated 
in just 4.4% of samples9. In a Canadian study conducted during an unknown time period 
following naturally infected pigs from 10-weeks until slaughter at 22 weeks of age, the most 
prevalent serovars shed in their feces were Typhimurium, Livingstone, Senftenberg, and 
Infantis10. Furthermore, the more common serovars involved in infection was different for the 
initial infection of pigs in the study, in which Salmonella Senftenberg and Salmonella 
Typhimurium were the most common, and re-infection at a later point in the study, in which 
Salmonella Livingstone was the most common10. The authors of this study proposed that re-
infection with a different serovar from what that pig was initially infected with may be due to a 
lack of cross-protection between the serovars of Salmonella10.  
 
Diagnostic testing for Salmonella  
Detection and identification methods for Salmonella are highly variable in their process, 
sensitivity, and specificity. Aside from differences in enrichment broths, selective agars, and 
timing of incubation of bacteriological culture methods, there are serologic tests and genetic tests 
available with the same variation in sensitivity and specificity. The International Organization 
for Standardization (ISO), an organization to which the United States is a member, provides 
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specifications for products, services, and systems in an effort to ensure the quality, safety, and 
efficiency of many products and procedures worldwide32. The current ISO procedure for 
Salmonella identification from the food chain via culture is as follows: pre-enrichment of sample 
in buffered peptone water (BPW) for 18 hours at 37˚C, transfer from BPW to Rappaport-
Vassiliadis (RV) broth or modified semisolid RV (MSRV) agar then incubate for 24 hours at 
41.5˚C while simultaneously transferring from BPW to Muller-Kauffmann Tetrathionate-
novobiocin (MKTTn) broth then incubating for 24 hours at 37˚C, then plate from selective 
enrichment to Xylose Lysine Deoxycholate (XLD) agar and an additional isolation agar and 
incubate for 24 hours at 37˚C, and finally test at least one suspect colony for confirmation as 
Salmonella species33. Testing only one suspect colony leaves a high risk of overlooking a less 
predominant serovar of Salmonella in a mixed infection of more than one serovar of Salmonella. 
Complete characterization to the serovar level is typically completed for only one colony per 
sample submitted to the majority of veterinary diagnostic laboratories as well, including the ISU-
VDL.  
Previous work has compared the sensitivity and specificity of five different culture 
methods for the isolation of Salmonella spp. from the feces of swine34. The methods, highly 
variable in terms of the media used and incubation times and temperatures, were as follows: 1) 
gram-negative (GN) brothRV brothxylose-lysine-tergitol-4 (XLT4) agar, each step 
incubated at 37˚C for 24 hours; 2) tetrathionate broth (TTB)RV brothXLT4 agar, all 
incubated at 37˚C, TTB incubated for 48 hours, RV broth and XLT4 agar incubated for 24 hours; 
3) peptone brothRV brothXLT4 agar, all incubated for 24 hours, peptone broth and XLT4 
incubated at 37˚C, RV broth incubated at 42˚C; 4) peptone brothRV plate, all incubated for 24 
hours, peptone broth incubated at 37˚C, RV plate incubated at 42˚C; 5) peptone 
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brothTTBXLT4 agar, all incubated for 24 hours, peptone broth and XLT4 agar incubated at 
37 degrees C, TTB incubated at 42˚C34. The highest sensitivity of any one method from swine 
fecal samples was 91.3% with method 2, while the other methods ranged from 0-80.4%34. 
Utilizing two of the methods simultaneously resulted in up to 100% sensitivity34. Unfortunately, 
it is not feasible for most diagnostic laboratories to use two methods for diagnosis of 
salmonellosis due to increased costs, time, and labor. In another study comparing different 
culture methods as well as PCR and ELISA testing, it was concluded that while the specificity 
was outstanding for all testing methods, ranging from 0.99-1, the sensitivity was much more 
variable, ranging from 0.23 with the OPTIMA ELISA test to 0.98 with the modified semi-solid 
Rappaport Vassiliadis (MSRV) agar and MSRV with PCR method35. The MSRV methods began 
with BPW as a non-selective enrichment broth, then transferred to MSRV agar, then either 
subcultured to XLD agar and brilliant green agar (BGA) or screened on the PCR35. Thus, it 
appears that while Salmonella diagnostics have an extremely low risk of false positives, there is a 
high risk of false negatives.  
Quantification of Salmonella in a sample can be an extremely useful measure for 
veterinarians and producers as it aids in describing the risk of herd-level spread of the 
organism12. Unfortunately, quantification presents unique difficulties. Differentiation of 
Salmonella from other fecal organisms poses a challenge even on Salmonella-selective agar12. 
Also, low numbers of organisms may be shed in feces, which further complicates enumeration of 
the bacteria. An enrichment step is often utilized to mitigate this problem which eliminates the 
ability to truly quantify the amount of Salmonella present in a sample12.  
For serologic testing, the serovar-specific antibody response must be known in order to 
interpret the results. In another study, pigs infected with low levels of Salmonella Typhimurium 
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and Salmonella Yoruba failed to exceed the threshold of the assay detecting anti-Salmonella 
antibodies at all sample collection time points, while pigs infected with a high level of 
Salmonella Typhimurium and Salmonella Yoruba had a peak seroprevalence by 14 days post 
infection (DPI) and 28 DPI, respectively12. In pigs infected with Salmonella Typhimurium, 
Salmonella Livingstone, or Salmonella Senftenberg, seroconversion occurred four weeks after 
the shedding of Salmonella in feces peaked10. In a different set of nursery pigs, sourced from 
known high-Salmonella prevalence farms and followed until slaughter, the serologic response to 
Salmonella Typhimurium infection peaked at 17 weeks of age, eight weeks after the peak fecal 
Salmonella shedding36. With the delay in antibody response relative to detectable levels of 
Salmonella in feces, serologic testing may be useful for determining previous Salmonella 
exposure in an individual animal that is culture-negative for Salmonella. Serology also 
overcomes the limitations of culture created by the variable shedding patterns, but only in the 
later stages of infection when seroconversion has occurred. Utilization of serologic and culture 
methods simultaneously may provide a better understanding of the overall current Salmonella-
status and history of an individual pig.  
Most recently, polymerase chain reaction (PCR) methods have been validated for 
Salmonella detection. These methods offer many advantages over culture, including reduced 
turnaround time, reduced subjectivity in reading tests, increased quantification ability, and 
potentially increased sensitivity and specificity. In one PCR assay targeting the invA gene, a gene 
common to all invasive Salmonella strains, to detect Salmonella spp. from equine feces, the 
specificity was 100% and the limit of detection was just 3-10 invA gene copies/μL DNA 
depending on whether or not enrichment broth was utilized37. A similar PCR assay was also 
validated to detect invA, and it was able to detect 67 Salmonella-positive samples while culture 
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detected merely 28, a sensitivity difference of 48-56% for culture and 87-95% for PCR (range 
determined by the Bayesian model assumptions applied)38. Although sensitivity was higher with 
PCR, the specificity of the PCR was less than 93% while culture was 100%38. In another 
quantitative real time PCR assay validated to differentiate Salmonella Enteritidis, Salmonella 
Typhimurium, and Salmonella 4,[5],12:i:-, there were four sets of primers and probes targeting 
safA for Salmonella Enteritidis identification, fliA, fljB-hin, and hin-iroB for Salmonella 
Typhimurium and Salmonella 4,[5],12:i:- identification39. The limit of detection of this assay 
was 3-14 gene copies (averaged across all gene targets)/PCR assay, although it varied slightly by 
each gene target39. In comparison of identification of serovar by PCR and culture, Salmonella 
Enteritidis matched for 99.0% of isolates while Salmonella Typhimurium and its variants 
matched for 98.2% of isolates39. The specificity of the PCR was 98%39. Other PCR tests have 
also been validated with the goal of detecting Salmonella in general or identifying specific 
serovars of Salmonella40-42.  
Selecting the appropriate sample type to maximize the efficacy of the diagnostic test is 
also critical and requires a balance between the ideal sample type and the sample type that can be 
reasonably collected. When comparing individual and pooled fecal samples from immature and 
adult cattle and swine, pooled fecal samples were better able to detect Salmonella from all 
groups except for adult, outdoor swine43. These findings are promising given that pooled fecal 
samples collected from the ground or floor are easier and more convenient to collect compared to 
individual fecal samples collected as the pig defecates or from the rectum. However, it is 
important to note that pooled fecal samples are obviously unable to determine the Salmonella 
status of each individual, which may be a problem if the goal is to treat only infected pigs rather 
than mass medication. Other sample types, aside from feces, are also available and include 
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environmental samples, oral fluids, and blood. Overall, the lack of standardization of Salmonella 
detection methods and the high level of variability between methods makes comparison of 
results from different laboratories and studies challenging. Further research to find more reliable 
methods of detection and quantification of Salmonella as well as the corresponding serovar-
specific antibody response would aid in the interpretation of Salmonella detection data obtained 
from various sources. 
 
Treatment of salmonellosis  
Antimicrobials are available for the treatment of Salmonella spp. infections in swine. In a 
study of the risks associated with Salmonella shedding from swine at the slaughter facility, the 
median survival time of Salmonella spp. within the host was reduced by up to 60% with 
treatment44. However, this study did not specify what treatment protocol was followed by the 
farms included in the study, only stating that the treatment typically included antimicrobial 
drugs. The United States Food and Drug Administration Green Book, a listing of all approved 
animal drug products that is updated monthly, lists drugs included in the antimicrobial classes of 
penicillins, cephems, sulfonamides, and tetracyclines as effective in the treatment and control of 
bacterial enteritis caused by Salmonella45. The most definitive way to select an antimicrobial for 
treatment of salmonellosis is to perform in vitro culture with subsequent antimicrobial 
susceptibility testing. However, the Clinical and Laboratory Standards Institute (CLSI) 
guidelines lack breakpoints specific to many drug-bacteria combinations in veterinary medicine, 
and therefore antimicrobial susceptibility testing of Salmonella isolates requires interpretation 
based on breakpoints in human medicine or for other bacteria. Prior knowledge and experience 
with a herd undergoing an outbreak of Salmonella in addition to an understanding of the typical 
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antibiograms of the likely infecting serovar can be used to initiate an appropriate treatment 
without antimicrobial susceptibility testing results46. Salmonella 4,5,12:i:- is often resistant to 
ampicillin, streptomycin, sulfisoxazole, and tetracycline, with 50% or more of isolates being 
resistant to each of those antibiotics47. Salmonella Typhimurium has a similar resistance profile, 
but is much less commonly resistant to those antibiotics, with only 25% or less of isolates being 
resistant47.  
Based on several research studies, there are some antimicrobials to potentially avoid 
given the reported increased virulence of Salmonella Typhimurium, and presumably its 
monophasic variant, in the host during treatment. One study demonstrated that tetracycline 
treatment of multidrug resistant (MDR) Salmonella Typhimurium led to up-regulated expression 
of three virulence genes although this did not necessarily correlate to increased host cell 
invasion48. All of the Salmonella Typhimurium isolates utilized in this study possessed one or 
more genes that are known to confer resistance to tetracyclines, which is not common among 
Salmonella Typhimurium13. Another study that looked at Salmonella Typhimurium treatment 
with chlorotetracycline showed that pigs treated with chlortetracycline had significantly higher 
levels of Salmonella in their feces on DPI 2 and in tonsils at necropsy on DPI 749. These findings 
are concerning given the potential for carcass contamination and subsequently pork product 
contamination as discussed previously. However, no other tissues, including distal ileum, 
ileocecal lymph nodes, cecal contents, and cecal mucosa, had an increased level of Salmonella 
when compared to non-chlortetracycline treated pigs49. Another study echoed those findings but 
determined that pigs treated with chlortetracycline shed higher levels of Salmonella 
Typhimurium up until DPI 7, rather than just on DPI 250. In a group of pigs treated with sub-
inhibitory concentrations of chloramphenicol, tetracycline, ampicillin, and streptomycin, both 
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chloramphenicol and tetracycline treatment increased the invasion abilities of Salmonella 
Typhimurium while ampicillin and streptomycin did not affect invasion51. Moreover, 
chloramphenicol and tetracycline reduced the expression of genes associated with motility of 
Salmonella while increasing the expression of genes associated with attachment and intracellular 
survival51. In addition to the aforementioned risks associated with certain antimicrobial 
treatments, there is also the increasing concern of development of and selection for antimicrobial 
resistant bacteria. It is well known that excessive use of antimicrobials promotes selection of 
antimicrobial resistance in the population of bacteria exposed to the drug52, therefore, it is of 
interest to reduce the overall impact of treatment of salmonellosis by utilizing alternatives that 
may have lower risks.  
With the risks associated with antimicrobial treatment, alternative management options 
for the treatment and control of Salmonella should be considered. Alternatives to antimicrobials 
can include heavy metals, such as zinc oxide or copper, and diet acidifiers. Zinc oxide added to 
the diet of pigs has been shown to be effective in improving average daily gain of four-week old 
weaned pigs when exposed to enterotoxigenic E. coli53. It also was able to increase the daily feed 
intake of the pigs and the gain-to-feed ratio53. Supplementation with zinc oxide also reduced the 
coliforms detectable in the ileum and colon while simultaneously increasing the ratio of lactic 
acid bacteria to coliforms in the intestines, indicating a positive effect on the gut microbiota53. 
Zinc oxide may also promote improved intestinal morphology, which may be beneficial in 
reducing the incidence and/or severity of enteric infections53,54. Copper can also be added to the 
diet and boasts the same potential outcomes as adding zinc to the diet54. Diet acidifiers show 
potential as antibiotic alternatives as they help to foster a gastrointestinal environment that 
promotes the growth of beneficial bacteria while potentially inhibiting growth of pathogenic 
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bacteria54. However, there are many different types of acids, including organic acids, inorganic 
acids, and acid salts, which may not have the same positive effects on pigs in general and 
especially on pigs exposed to Salmonella54. The simultaneous addition of organic acids, 
phytochemicals, and a permeablizing complex to the diet of pigs reduced the fecal shedding of 
Salmonella 4,[5],12:i:- at weeks 3, 6, and 855. However, this combination of feed additives did 
not show the same beneficial effect on the average daily gain, feed conversion ratio, or daily feed 
intake55. With this being a relatively new concept for bacterial control, it is not surprising that 
more research must be done to determine the exact effects of various acids and metals to ensure 
the desired outcome is achievable.  
 
Salmonella 4,[5],12:i:-  
Origin  
With over 2500 serovars of Salmonella and more serovars still being discovered or 
emerging, some serovars have a well-understood pathogenesis, virulence, host species range, and 
general characteristics while others are severely lacking in this critical information. Many 
questions remain unanswered about the monophasic Salmonella 4,[5],12:i:-, including the cause 
of its emergence, the preferred host species, and resulting disease. Monophasic serovars of 
Salmonella in general could have originated from two main sources: 1) ancestral serovar that 
never developed the necessary mechanism to express a second flagellar phase or to switch from 
phase 1 to phase 2 flagella, or 2) mutation from a diphasic serovar56. Beginning with the 
antigenic formula, 4,[5],12:i:-, it is evident that this serovar belongs to serogroup B Salmonella 
which share common somatic antigens 4 and 1257. Salmonella Lagos (4,[5],12:i:1,5) and 
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Salmonella Typhimurium (4,[5],12:i:1,2) are the only two serovars that possess the same somatic 
and phase 1 flagellar antigens57,58. 
Based on the higher prevalence of Salmonella Typhimurium in comparison to Salmonella 
Lagos, the two most likely serovars from which this monophasic serovar was derived, it is more 
likely that Salmonella 4,[5],12:i:- originated from Salmonella Typhimurium58. An insertion 
sequence, IS200, was identified in Salmonella and Escherichia coli and is located in the 
intergenic region of fliA and fliB59. In the comparison of different serovars, Salmonella 
Typhimurium isolates possessed an amplicon of 1135 base pairs (bp) long while other serovars 
examined had only 424 bp long amplicons59. In alignment with the thought that Salmonella 
4,[5],12:i:- originated from Salmonella Typhimurium, Salmonella 4,[5],12:i:- has been shown to 
possess a 1000 bp fliA-fliB intergenic region similar to that reported in Salmonella Typhimurium 
and in contrast to that of other serovars, including Lagos, Agona, Derby, and others which have 
250 bp long intergenic regions58,60. Although there are slight inter-study differences in the length 
of the intergenic region of Salmonella Typhimurium and Salmonella 4,[5],12:i:-, the conclusion 
that each study reached is the same: Salmonella 4,[5],12:i:- possesses an IS200 sequence which 
closely resembles that of Salmonella Typhimurium.  
 
Pulsed-field gel electrophoresis (PFGE) 
PFGE can be utilized to compare the degree of relation between isolates, including 
isolates of different serovars as well as of the same serovar. When evaluating isolates of 
Salmonella from China, PFGE completed using enzyme XbaI revealed that 30 Salmonella 
Typhimurium isolates were identical to five Salmonella 4,[5],12:i:- isolates, signifying a possible 
relation between the two serovars28. Characterization of Salmonella 4,[5],12:i:- from Switzerland 
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by PFGE using XbaI showed that, of the 758 Salmonella 4,[5],12:i:- isolates evaluated, there 
were more than 150 different pulsotypes but only seven dominant pulsotypes contained the 
majority (66%) of the isolates29. This indicates that there is likely a close ancestral relation of 
these isolates. PFGE combining the profiles created by both XbaI and BlnI restriction enzymes 
resulted in at least 85% similarity among 69% of the tested Salmonella 4,[5],12:i:- isolates61. 
This also indicates that there is likely a close common ancestor of at least those isolates, 
however, greater than 31% of the isolates did not share that level of similarity and may have 
arisen from a less closely-related ancestor61. 
 
Multiple-locus variable analysis (MLVA) 
While serotyping is a common method applied in the United States for subtyping of 
Salmonella to aid in determination of the source in epidemiological studies, phage typing, 
antimicrobial resistance profiles, and multiple-locus variable analysis (MLVA) are among some 
of the other options available and applied in other countries62. MLVA has some challenges when 
it comes to long-term surveillance due to evolution of the variable number tandem repeats 
(VNTR) that are targeted by MLVA, but there is a place for MLVA in tracing outbreaks given 
the high level of discrimination and reproducibility it provides62. In a comparison of 411 
Salmonella 4,[5],12:i:- and 182 Salmonella Typhimurium isolates from Italy using MLVA, the 
isolates were broken into seven clusters, five of which contained isolates from both serovars63. 
Given the serovar specificity of MLVA, this further substantiates the hypothesis that Salmonella 
4,[5],12:i:- is a variant of Salmonella Typhimurium62,63. The relatively low variability in MLVA 
profiles of Salmonella 4,[5],12:i:- isolates in comparison to Salmonella Typhimurium isolates 
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increases the likelihood that Salmonella 4,[5],12:i:- emerged much more recently, which is not 
surprising given the serovar prevalence changes over the recent years as discussed previously63.  
Some MLVA profiles of human-origin isolates have been shown to be very similar or the 
same as isolates from food producing animals, indicating a potential spread from one to the 
other63. This finding was supported by the results of another study evaluating isolates from 
Belgium which reported some profiles of isolates from humans were identical to those of 
livestock64. When comparing Salmonella 4,[5],12:i:- isolates from France using MLVA, there 
was significant overlap in MLVA type and the source, meaning that each MLVA type was found 
in the live pig, pork products, and humans, indicating a spread from one to the other65.  
 
Phage typing 
Phage typing is based on the ability of certain bacteriophages to infect an isolate of 
Salmonella, determined by the presence of appropriate receptors on the bacterial cell wall and 
genetic characteristics of the bacteriophage66. The phage type of an isolate is reported as the 
bacteriophage or bacteriophages that are able to lyse the Salmonella66. Further evaluation of 40 
4,[5],12:i:- isolates from Switzerland through phage typing showed that 55% of them were 
DT193, 15% were DT104b, 10% were DT120, and 2.5% were DT7, with the remaining isolates 
unable to be typed29. All of these phage types have been reported in Salmonella Typhimurium. 
Other studies comparing the two serovars to one another reached similar conclusions, with both 
Salmonella 4,[5],12:i:- and Salmonella Typhimurium isolates having phage types U302, DT120, 
and DT19327,65. Another study looking at the origin of Salmonella 4,[5],12:i:- determined that the 
majority (70%) of evaluated Salmonella 4,[5],12:i:- isolates are phage type U30261. In an 
evaluation of isolates from Korea, the most common phage types are DT193, DT104b, and 
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DT208, all of which are shared with Salmonella Typhimurium67. When evaluating phage types 
in different serovars of Salmonella, it was determined that a genomic region was found only in 
DT104 and DT U302 Salmonella Typhimurium and Salmonella 4,[5],12:i:- isolates but absent in 
Salmonella Lagos, providing further evidence that Salmonella 4,[5],12:i:- arose from Salmonella 
Typhimurium rather than Salmonella Lagos68. Phage types, or definitive types, are highly 
specific to even the serovar level69,70, so the commonality between Salmonella Typhimurium and 
Salmonella 4,[5],12:i:- phage types provides additional evidence that Salmonella 4,[5],12:i:- 
originated from Salmonella Typhimurium.  
 
Whole-genome sequencing (WGS) 
Whole-genome sequencing has recently become a more widely used genotyping method 
due to improved affordability and accessibility71. This method provides a higher resolution of 
closely related isolates than other genotyping methods71. Although whole-genome sequencing 
has not been widely utilized for characterization of bacterial isolates, a few studies have been 
published comparing Salmonella 4,[5],12:i:- to Salmonella Typhimurium. In one study, it was 
determined that Salmonella 4,[5],12:i:- isolates from swine the Midwestern United States had a 
high level of similarity with Salmonella Typhimurium isolates from Europe72. Another study 
found that, of the 32 total Salmonella Typhimurium and Salmonella 4,[5],12:i:- isolates 
analyzed, Salmonella Typhimurium isolates were closely related to Salmonella 4,[5],12:i:- 
isolates73. 
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Polymerase chain reaction (PCR) 
In the study of Belgium isolates, based on PCR assays in accordance with the 
recommendations of the European Food Safety Authority (EFSA), 194 of the 253 Salmonella 
4,[5],12:i:- isolates were confirmed to be monophasic variants of Salmonella Typhimurium with 
an absence of fljB amplification and presence of IS200 element74. The remaining Belgium 
isolates, 59 of 253, although they phenotypically presented as monophasic isolates, had 
maintained a biphasic molecular status74. Similar findings were reported from another study of 
monophasic isolates with 18.9% of these isolates being positive for the portion for the fljB gene 
targeted by the PCR primers, even though they were phenotypically monophasic75.  
In a comparison of Salmonella Typhimurium and Salmonella 4,[5],12:i:- isolates as well 
as a comparison of Salmonella 4,[5],12:i:- isolates from the United States, Spain, and Thailand, 
differences were revealed in the presence or absence of typical flagella-related genes based on 
location of origin and serovar76. Primers for this comparison included three that are considered 
highly specific for Salmonella Typhimurium and four others that were involved in the phase 2 
flagellin expression, including fliA, fljB, hin, and iroB68,76. The Spain and Thailand-origin 
Salmonella 4,[5],12:i:- isolates were positive for two of the three Salmonella Typhimurium 
specific targets while the US-origin Salmonella 4,[5],12:i:- isolates were positive for only one of 
the three76. Additionally, the Spain-origin isolates were negative for all four targets related to 
phase 2 flagella while the US and Thailand-origin isolates were negative for all four targets 
except for iroB76. Another study compared a PCR assay that detects three Salmonella 
Typhimurium-specific regions and had been successfully tested against 117 other serovars of 
Salmonella to ensure a lack of cross-reactivity; the only serovar aside from Salmonella 
Typhimurium that tested positive for those three regions was Salmonella 4,[5],12:i:-60.  
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Monophasic phenotype 
Flagellar phase variation in Salmonella is a complex process, requiring the expression 
and functionality of multiple genes. In biphasic Salmonella serovars, the phase 1 flagellin is 
encoded by fliC while the phase 2 flagellin is encoded by fljB77. Only one flagellar phase is 
expressed at any one time, so there is a process by which the expressed flagellin is switched from 
phase 1 to phase 2 and phase 2 to phase 1. In a wild-type Salmonella Typhimurium, the amount 
of switching from phase variation from fljB to fliC and vice versa in vitro were 0.036 and 0.011 
colonies switched per colonies tested, respectively, with similar rates of phase variation obtained 
from Peyer’s patches and spleen of mice inoculated with Salmonella Typhimurium78. In a 
genomic region adjacent to fljA and fljB, known as the H segment, the fljAB promoter and hin 
gene are located77,79. The hin gene encodes a recombinase, which works in conjunction with the 
fis gene, HU gene, and host factors to regulate the reversible recombination of hixL and hixR, the 
regions flanking hin80-82. As recombination occurs at hixL and hixR, one of two outcomes occurs 
based on its orientation: 1) fljAB promoter is transcribed to cause fljB expression and fljA 
expression with subsequent fliC inhibition; or 2) fljAB promoter is not transcribed and 
subsequently fljA and fljB are not expressed, leading to fliC expression79-81.  
The exact cause of the absence of phase 2 flagellar antigen expression in Salmonella 
4,[5],12:i:- is not known and likely varies by the origin and evolution of each isolate. The 
absence could be caused by a change in the promoter region of the fljA and fljB operons or in fliA 
or hin due to their roles in regulation of phase 2 flagellar expression60,83,84. As discussed 
previously with respect to the variation in the PCR testing results obtained by multiple studies of 
Salmonella 4,[5],12:i:- isolates, there is a significant amount of dissimilarity in the genetic 
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composition and gene expression of this serovar. The absence of phase 2 flagellar expression 
could originate from dysfunction in other parts of the process of flagellar expression aside from 
the sequence of the gene, including protein translocation, gene expression, and flagellar filament 
assembly75.  
The effect of the absence of the phase 2 flagellar expression on the ability of Salmonella 
4,[5],12:i:- to cause clinical disease remains largely unknown. The outcome of infections with 
Salmonella Typhimurium in mice were much different, based on whether the bacteria were 
predominantly expressing fljB or fliC at the time the mice were inoculated78. Of the mice 
inoculated with primarily fljB-expressing Salmonella Typhimurium, 14 out of 14 mice survived 
to the completion of the study while only 10 out of 14 mice inoculated with primarily fliC-
expressing Salmonella Typhimurium survived78. In addition, 87% of the Salmonella that was 
isolated from the fliC-expressing Salmonella Typhimurium inoculated mice were expressing 
fliC78. In contrast, only 60% of the Salmonella isolated from the Peyer’s patches of 13 of the 14 
mice infected with fljB-expressing Salmonella were still expressing fljB78. It is worth noting that 
in the spleen of mice that were infected with fljB expressing Salmonella, the majority of the mice 
were expressing primarily fliC by DPI 2178. It is possible that fliC provides a selective advantage 
in mice, although the translation to swine from this study is unclear.  
Flagella, regardless of the phase, play an important role in the pathogenesis of 
Salmonella. Flagella are required for motility, which is subsequently required for a bacterium to 
interact with and invade a host cell85. There is also evidence that the flagella aids in selection of 
the target site of invasion, which would potentially alter the overall effect of that Salmonella 
infection on the host85. It seems logical to conclude that flagella are critical for the pathogenicity 
of Salmonella in the host, but the benefit or detriment of possessing two phases of flagella 
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remains unclear. To study this, an in vitro analysis was conducted comparing Salmonella 
4,[5],12:i:- and Salmonella Typhimurium in porcine intestinal epithelial cells86. While the non-
motile variant of Salmonella Typhimurium had a reduced ability to adhere to and invade the 
porcine intestinal epithelial cells when compared to biphasic Salmonella Typhimurium, the 
monophasic Salmonella 4,[5],12:i:- isolate evaluated in this study had equivalent adhesion and 
invasion capabilities86. However, there were biphasic Salmonella Typhimurium strains in this 
study that had an impaired adhesion and invasion ability86, which indicates that there is also 
within-serovar variation that could not be thoroughly evaluated based on this data given the 
small number of isolates compared. It is also well known that flagella stimulate the release of 
signaling molecules to induce an inflammatory response in the intestine of the host86-88. TLR-5 
and interleukin-8 were upregulated upon infection with Salmonella 4,[5],12:i:-, indicating that 
this serovar is equally antigenic to its biphasic counterpart86,89. In a recent study of eight pigs 
experimentally infected with a multidrug-resistant strain of Salmonella 4,[5],12:i:-, a disease 
similar to that commonly observed with Salmonella Typhimurium infection occurred, including 
fever and diarrhea90.  
 
Cause of emergence 
One of the questions about Salmonella 4,[5],12:i:- that remains unanswered, and 
potentially can never be answered with complete certainty, is the underlying cause of its rapid 
increase in identification over the past couple of decades. Several theories have been proposed in 
the literature which will be discussed here. Salmonella 4,[5],12:i:- tends to have a high level of 
resistance to antimicrobials. Of 110 Salmonella 4,[5],12:i:- isolates from humans evaluated in the 
National Antimicrobial Resistance Monitoring System (NARMS) in 2014, 27.9%, 34.2%, 9.8%, 
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and 6.5% were resistant to three or more, four or more, five or more, and six or more 
antimicrobial classes per Clinical and Laboratory Standards Institute (CLSI), respectively47. The 
antimicrobial classes include aminoglycosides, beta-lactams, cephems, macrolides, penicillins, 
quinolones, folate pathway inhibitors, phenicols, and tetracyclines47. In 2014 human-origin 
Salmonella 4,[5],12:i:- isolates, greater than 50% of the isolates were resistant to one or more of 
the following antimicrobials: streptomycin, ampicillin, sulfisoxazole, and tetracycline47. When 
comparing this level of resistance to that of Salmonella Typhimurium, only 25% or less of the 
Salmonella Typhimurium isolates in the NARMS study were resistant to the same antimicrobials 
of concern as Salmonella 4,[5],12:i:-47. In a study of swine in Spain, 100% of the Salmonella 
4,[5],12:i:- isolates from clinically ill pigs were considered multidrug resistant (resistant to four 
or more antimicrobials) while 84.6% of Salmonella 4,[5],12:i:- from clinically healthy pigs were 
multidrug resistant; both of these percentages were higher in Salmonella 4,[5],12:i:- than 
Salmonella Typhimurium in each of the populations (clinically healthy versus ill)91. There have 
been many other reports on the antimicrobial resistance of Salmonella 4,[5],12:i:- isolates from 
different species and different countries, all with the same conclusion that this serovar is 
generally highly resistant to antimicrobials29,61,67,92. Given the extensive use of antimicrobials in 
both humans and livestock production, it is possible that antimicrobial resistance may provide a 
selective advantage to the success of the monophasic serovar.  
In addition to antimicrobial resistance, resistance to heavy metals may also have some 
role in the emergence of Salmonella 4,[5],12:i:-. Some strains of Salmonella 4,[5],12:i:- possess 
a genomic island known as SGI-3, which encodes genes that confer resistance to heavy metals 
such as copper sulfate and zinc93. Another study had similar findings in which the majority 
(44/50) of isolates were determined to be resistant to copper and silver due to the presence of the 
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pcoA-pcoD and silA-silE genes, respectively94. Some isolates have also been shown to be 
resistant to mercury and tolerant of cations and arsenic94. Given the increased use of heavy 
metals in livestock feed to replace the role of antimicrobials53,54, the resistance to heavy metals 
may also provide some advantage to the serovars’ survivability. Another cause may be that 
Salmonella 4,[5],12:i:- possesses a competitive advantage over Salmonella Typhimurium within 
and outside of the host. Outside of the host, the majority of the monophasic serovar isolates have 
been shown to possess the ability to form biofilms, which would enhance the survivability while 
reducing the effects of antimicrobials95,96. Although the biofilm formation ability may enhance 
the survival of Salmonella 4,[5],12:i:-, the role of this in the emergence of Salmonella 4,[5],12:i:- 
remains unclear as Salmonella Typhimurium has a similar biofilm formation ability96. 
Salmonella 4,[5],12:i:- also commonly possesses multiple virulence genes that could contribute 
to its survival within its host and environment; these genes include but are not limited to sipC 
which is involved in cell adhesion and invasion, sopB which is involved in the intestinal changes 
that lead to diarrhea, and hilA which activates the invasion process97. The combination of biofilm 
formation and presence of many virulence genes that function in the pathogenesis of Salmonella 
4,[5],12:i:- may be the source of the competitive advantage in vivo. This is an area that needs 
further research to determine the exact cause for emergence, as this may help control this serovar 
in the animal reservoir and its transmission to humans.  
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Abstract 
The rapid identification of the infecting Salmonella serovar from porcine diagnostic 
samples is vital to allow implementation of appropriate on-farm treatment and management 
decisions. Although identification at the serogroup level can be rapidly achieved at most 
veterinary diagnostic laboratories, final Salmonella serovar identification often takes several 
weeks because of the limited number of reference laboratories performing the complex task of 
serotyping. Salmonella serogroup B, currently the dominant serogroup identified from swine 
clinical samples in the United States, contains serovars that vary from either highly pathogenic to 
minimally pathogenic in swine. We determined the frequency of detection of individual Group B 
serovars at the Iowa State Veterinary Diagnostic Laboratory (ISU-VDL) from 2008 – 2017, and 
validated a multiplex real-time PCR (rtPCR) to distinguish pathogenic serogroup B serovars 
from those of lesser pathogenicity. Our results indicate that, since 2014, S. 4,[5],12:i:- has been 
the dominant serovar identified from swine clinical samples at the ISU-VDL, with S. 
Typhimurium now the second most common serovar identified. A rtPCR was developed to allow 
rapid differentiation of samples containing S. 4,[5],12:i:- and S. Typhimurium from samples 
containing serovars believed to be of less pathogenicity, such as S. Agona and S. Derby. When 
combined with enrichment culture, this rtPCR has the ability to significantly improve the time to 
final serovar diagnosis of the 2 most commonly identified pathogenic Salmonella serovars in 
swine, and allows for rapid implementation of serovar-specific intervention strategies.  
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Introduction 
Non-typhoidal Salmonella enterica infections in swine can result in clinical disease (i.e., 
salmonellosis) or asymptomatic infections, with clinical disease most commonly observed in 
weaned, growing, and finishing pigs.23 Although clinical disease typically occurs as fever with 
diarrhea, the clinical manifestation of Salmonella enterica infection is highly dependent on the 
infecting serovar and age of the pigs.19,23 Subclinical infections present unique diagnostic 
interpretation challenges given that pigs are infected with Salmonella without any clinical signs 
of disease but will often shed the organism in their feces for an extended period of time.8,45 
Variation between pigs and inconsistencies in shedding patterns make it difficult to confidently 
confirm that an animal is truly negative for a current Salmonella infection,9,31 which poses a risk 
of continued environmental contamination leading to exposure of cohorts. Hence, it is not 
surprising that a high prevalence of non-typhoidal Salmonella serovars has been documented 
among finishing pigs at slaughter.3,29,42  
Salmonella shedding around the time of slaughter, including transport and lairage, 
increases the risk of contamination of pork products with Salmonella. This is of concern given 
that Salmonella enterica is the most commonly reported cause of foodborne illness in humans.11 
There are significant differences in the contribution of each serovar to human disease risk; those 
that lack host restriction, such as S. Typhimurium, are of primary importance. Salmonella 
Typhimurium has been widely recognized as a cause of foodborne illness in humans for many 
years, especially with regard to contaminated pork products.13,30,44 More recently, the 
monophasic variant of S. Typhimurium, S. 4,[5],12:i:-, has been implicated as an increasingly 
common cause of human illnesses.6,24,33,36 
It is widely accepted that S. 4,[5],12:i:- is a variant of S. Typhimurium, based on 
molecular subtyping through pulsed-field gel electrophoresis, multilocus sequence typing, phage 
38 
 
 
typing, and plasmid characterization.2,27,28,41 Although S. Typhimurium expresses the “i” phase 1 
flagellar antigen and the “1 and 2” phase 2 flagellar antigens, the 4,[5],12:i:- serovar lacks phase 
2 flagellar expression.41 Although S. 4,[5],12:i:- is considered a S. Typhimurium variant, 
worldwide, it has been demonstrated that there are many clones originating from multiple 
independent events. These events resulted in deletions or mutations in various genomic regions 
including: hin (which encodes a recombinase that regulates inversion of the fljAB promoter), fljB 
(which encodes the phase 2 flagellar proteins), or the fljAB promoter region.37,41 Minimal data 
exists at this time detailing the emergence of S. 4,[5],12:i:- in the United States. Of the 51 
isolates recovered from swine between 2014-2016 that were evaluated via whole genome 
sequencing, 48 were part of a single emerging clade.18 However, this work was limited to 
samples submitted from the midwestern United States only, and it was unclear how many 
production units were represented in the dataset and thus whether the study was representative of 
the current population of S. 4,[5],12:i:- circulating in the United States.  
In a review of case data from clinical submissions to the ISU-VDL during an 18-mo 
period of 2016-2017, a statistically significant positive association between histologic lesions 
consistent with enteric salmonellosis and isolation of Salmonella 4,[5],12:i:- was noted.1 A 
small-scale pathogenicity study utilizing a multi-drug resistant isolate from a human outbreak 
also reported the ability of S. 4,[5],12:i:- to cause disease in swine similar to that seen in previous 
studies utilizing S. Typhimurium in the same laboratory.40 These findings are consistent with an 
in vitro study that compared the ability of an S. 4,[5],12:i:- isolate and an S. Typhimurium isolate 
to adhere to and invade cultures of porcine intestinal epithelial cells, determining that there was 
no difference between the 2 serovars in their cytotoxicity, colonizing ability, or effect on pro-
inflammatory chemokine release.14 Thus, without additional available data to the contrary, it 
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seems reasonable to consider S. 4,[5],12:i:- to be of similar pathogenicity to S. Typhimurium in 
swine. However, although vaccines to aid in the prevention of disease caused by S. Typhimurium 
in swine are available commercially in the United States, there are no vaccines similarly labeled 
for control of S. 4,[5],12:i:-. Given that no research has been published to date on the potential 
for cross-protection of vaccination against S. Typhimurium on the incidence of S. 4,[5],12:i:- in 
swine operations, and although pathogenicity may be equivalent, successful prevention strategies 
may not be identical between the serovars. In addition, evaluation of antimicrobial resistance 
patterns of S. 4,[5],12:i:- isolates from humans has shown these isolates to be more highly 
resistant to several different classes of antibiotics compared to human isolates of S. 
Typhimurium, thus effective treatment of clinical disease in swine may differ between the 
serovars.11 
Both S. Typhimurium and S. 4,[5],12:i:- are part of Salmonella serogroup B. From the 
late-1990s through the mid-2000s, S. Typhimurium and S. Derby were reported as the most 
frequently isolated Group B serovars from swine in the United States.20 Interestingly, Salmonella 
4,[5],12:i:- was rarely identified prior to the mid-1990s.41 This serovar first appeared in Europe, 
where it is now the third most frequently isolated serovar from human salmonellosis cases.16 In 
the United States, it was the fifth most frequently isolated serovar from human enteric 
salmonellosis in 2014, increasing in prevalence by 194% from 2005 to 2015.12 From July 2006 
through June 2015, the Minnesota Veterinary Diagnostic Laboratory reported the most frequent 
Salmonella serovars isolated from swine sample submissions (n = 2,537) were S. Typhimurium 
var 5- (28.2%), S. Agona (14.7%), and S. Derby (12.1%).26 The Minnesota study26 as well as a 
national study incorporating both human and veterinary data46 both noted an increase in isolation 
of S. 4,[5],12:i:- similar to that initially reported by the Iowa State University Veterinary 
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Diagnostic Laboratory (ISU-VDL) in late 2016 (Krull A, et al. Increased frequency of isolation 
of multi-drug resistant Salmonella I 4,[5],12:i:- from swine with histologic lesions consistent 
with salmonellosis. Proc Am Assoc Vet Lab Diagnosticians Ann Conf. Oct 2016. Greensboro, 
NC). According to the 2013 NARMS Retail Meat Interim Report, S. 4,[5],12:i:- was identified as 
one of the serovars most commonly isolated from retail pork in the United States.12 It is worth 
noting that S. 4,[5],12:i:- has been detected in cattle15,26,32 and poultry12,15 in addition to 
swine.5,26,43 
Rapid detection and identification of Salmonella, particularly serovars such as S. 
Typhimurium and S. 4,[5],12:i:- that are believed to be pathogenic to both pigs and humans, is 
critical for preventing foodborne illness outbreaks. Implementation of suitable treatment and 
prevention protocols on farms is reliant on rapid detection and identification of pathogens, which 
subsequently aids in reducing potential pork contamination. Current protocols for Salmonella 
isolation, identification, and serogrouping take 3-5 d on average.34 However, serotyping at a 
reference laboratory can take 4-6 wk. The extended time to final identification at the serovar 
level limits the ability of veterinarians and producers to begin the most appropriate treatment and 
prevention protocols. Our objectives were: 1) to determine the frequency of detection of various 
Group B serovars commonly identified from swine at the ISU-VDL from 2008 to 2017, and 2) to 
develop a multiplex real-time PCR (rtPCR) to rapidly detect and differentiate Salmonella 
serovars likely to be pathogenic in swine (i.e., S. Typhimurium and S. 4,[5],12:i:-) from those of 
lesser pathogenicity (e.g., S. Derby) from clinical specimens. 
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Materials and methods 
Retrospective analysis of ISU-VDL data 
The ISU-VDL receives >75,000 case submissions annually, ~75% of which are samples 
from all types of swine production systems throughout the United States. The ISU-VDL 
Laboratory Information Management System provided data for the analysis of the frequency of 
detection of specific serovars of Salmonella, using search criteria which included: 1) the period 
from January 1, 2008 through December 31, 2017; 2) all porcine cases from which a Salmonella 
species was isolated from a clinical specimen (primarily feces or tissues); 3) the isolate was 
verified as Salmonella and the serovar identified by the National Veterinary Services 
Laboratories (NVSL); and 4) the isolate had antimicrobial susceptibility testing performed. All 
submissions considered research cases or cases in which Salmonella isolate serotyping was 
unable to be performed were eliminated from analysis. When multiple Salmonella isolates were 
isolated from a single case, the standard laboratory protocol was to send only a single isolate to 
NVSL for serotyping, therefore, each isolate listed in our analysis represents a unique case 
submission to the ISU-VDL. 
 
Culture, isolation, and DNA extraction of bacterial samples 
All bacterial isolates used for validation were selected from clinical samples submitted to 
the ISU-VDL. Porcine samples submitted for routine enteric culture were plated onto 4 different 
agar plates/atmospheric conditions for isolation of pathogens associated with enteric disease. 
These included 1) tryptic soy agar (TSA) with 5% sheep blood (Remel Products, Lenexa, KS) 
incubated under 5% CO2, 2) TSA with 5% sheep blood incubated anaerobically, 3) brilliant 
green agar with novobiocin (BGN) (in-house) incubated aerobically, and 4) tergitol-7 agar (T7) 
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(Remel Products) incubated aerobically. All plates were incubated at 35°C for a minimum of 48 
h. Colonies consistent with Salmonella were selected from the BGN and/or T7 plates, 
subcultured to TSA to obtain pure cultures, and saved in 10% glycerol stocks for long-term 
storage at -80°C for further use. 
Upon request from a diagnostician with clinical suspicion of salmonellosis, a 24-h 
enrichment with either tetrathionate broth or buffered peptone water (BPW) was also included in 
select cases. For these samples, the enrichment culture was incubated at 42°C and then was sub-
cultured onto BGN, which was incubated aerobically for 24 h. 
Confirmation of suspect isolates was done via matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) following the manufacturer’s 
recommendations (Bruker Daltonics, Billerica, MA). A minimum MALDI-TOF-MS confidence 
score of 2.10 was required for confirmatory identification. Confirmation of Salmonella 
identification was then followed by serogrouping via slide agglutination testing (BD Diagnostics, 
Sparks, MD; SSI Diagnostica, Herredsvejen, Denmark) at ISU-VDL and serotyping at NVSL. 
Bacterial isolates from routine cases were saved at -80°C in brain heart infusion (BHI) 
broth with 10% glycerin. Stored isolates selected for use in validation of the rtPCR were cultured 
onto TSA with 5% sheep blood agar and incubated at 35°C for 24 h to ensure purity prior to 
DNA extraction. 
DNA extraction of pure culture of bacterial isolates was achieved first by suspension of 
multiple colonies of the culture in phosphate-buffered saline (PBS). DNA extraction of the 
samples was then performed (RNA DNA Pathogen extraction kit; Kingfisher rapid throughput 
DNA extraction system; Thermo Fisher Scientific, Rochester, MN) according to manufacturer’s 
recommendations.  
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Development of rtPCR 
The rtPCR assay was designed to detect the following genes or regions: invA (present in 
all Salmonella,21 fliA (present in both S. Typhimurium and S. 4,[5],12:i:-),17,25 fljB (present in S. 
Typhimurium, may be absent in S. 4,[5],12:i:-),7,29,28,41 the intergenic space between hin and iroB 
(present in S. Typhimurium, may be absent in S. 4,[5],12:i:-),7,29,41 and an internal control (see 
Table 1). To be considered S. 4,[5],12:i:-, one or both of either the fljB or hin-iroB targets must 
be absent (negative) to result in the monophasic variant. The primers and probes were designed 
and validated previously (Supplementary Table 1).35,38 Controls for each rtPCR assay included 
an internal amplification control, 2 positive extraction controls, a negative extraction control, and 
a negative amplification control. The internal amplification control consisted of G-block gene 
fragments 125-500 bp (XIPC_IVT; Integrated DNA Technologies; 149551620) based on the 
GenBank sequence DQ883679, as described previously.39 The positive extraction controls 
included one S. Typhimurium isolate and one S. 4,[5],12:i:- isolate, both at a concentration of 104 
CFU/mL suspended in Luria-Bertani (LB) broth. The negative extraction control was nuclease-
free water (Life Technologies, Waltham, MA). The negative amplification control was the 
prepared rtPCR master mix.  
Real-time PCR assays were carried out in 25 µL reactions (QuantiTect Virus + ROX kit; 
Qiagen, Waltham, MA) according to the manufacturer’s recommendations, with each target 
primer at a final concentration of 200 nM, each target probe at 100 µM, and XIPC primers and 
probe at final concentrations of 160 and 60 nM, respectively. A Rotor Gene-Q 5-plex HRM 
thermocycler system (Qiagen) was used with the following cycling conditions: 20 min at 50°C, 5 
min at 95°C, then 40 cycles of alternating 15 s at 95°C and 1 min at 60°C. The initial 20-min 
step was included to allow simultaneous testing with other reverse-transcription rtPCRs run in 
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the testing laboratory. The threshold for analysis was set at 0.02. The following interpretation 
criteria were used for all sample types. The negative cut-off for detection of any Salmonella 
DNA, regardless of serovar, present in the sample was maintained at a cycle threshold (Ct) value 
of 40, as is standard in the ISU-VDL; the sample was considered positive for the presence of any 
Salmonella DNA below this threshold. A sample was considered positive and able to be 
identified at the serovar level if the Ct was <30. If the Ct was 30-40, it was considered positive 
for Salmonella DNA but inconclusive for serovar identification. Therefore, further testing 
utilizing additional culture and/or enrichment followed by NVSL serotyping or repetition of 
rtPCR on pure culture was necessary for serovar identification in some samples.  
 
Inclusivity and exclusivity 
To assess the inclusivity of the rtPCR, 61 S. 4,[5],12:i:- isolates and 45 S. Typhimurium 
isolates were tested. To assess the exclusivity of the rtPCR, 38 isolates, representing 28 non-
Typhimurium, non-4,[5],12:i:- serovars of Salmonella and 7 non-Salmonella organisms 
commonly found in feces, were tested (Supplementary Table 2). Salmonella serovars selected for 
exclusivity testing included the 10 serovars isolated most commonly from porcine samples at the 
ISU-VDL as well as serovars that are closely related to the serovar Typhimurium. All isolates 
tested were obtained from previous ISU-VDL case submissions using the culture techniques 
described above. 
 
Limit of detection studies 
Two limit of detection studies were completed, one with and one without enrichment in 
BPW prior to DNA extraction and rtPCR. Enrichment in BPW has been shown in the ISU-VDL 
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to be a superior method, relative to tetrathionate broth, for enriching for Salmonella sp. in 
clinical and environmental samples prior to rtPCR (Krull A, et al. Use of enrichment and 
quantitative PCR to improve detection of Salmonella in referral hospitals. Am Coll Vet Intern 
Med (ACVIM) Forum Research Report, June 2016, Denver, CO). To determine the non-enriched 
limit of detection, the following method was repeated with one S. Typhimurium and one S. 
4,[5],12:i:- isolate each using Salmonella-negative feces (confirmed by enrichment culture) as 
the sample medium. To prepare the dilutions, a 0.5 McFarland standard (~1.5 x 108 CFU/mL) 
was prepared from a pure culture and then serially diluted 1:10 in PBS. The actual amount of 
Salmonella in each dilution was determined using the standard plate count method on TSA with 
5% sheep blood agar. Salmonella, in the form of 0.5 mL of the serially diluted McFarland 
standard, was added to 0.2 gram of porcine feces to create 10-fold dilutions of Salmonella from 5 
x 107 to 5 x 101 CFU/mL. Each dilution was created in triplicate. Salmonella was also added to 
feces to create 5-fold dilutions of Salmonella from 1x104 – 1x101 CFU/mL, again in triplicate. 
DNA from the fecal samples was extracted using the bead beating method recommended in the 
ThermoFisher Total Nucleic Acid kit insert, using the RNA DNA Pathogen Extraction kit and 
100 µm acid-washed zirconium bead-filled tubes (OPS Diagnostics, Lebanon, NJ). 
The post-enrichment limit of detection was determined by adding 250 µL of the fecal 
samples created for the non-enrichment limit of detection studies to 5 mL of BPW. The 
inoculated BPW was then incubated at 35°C for 18-24 h prior to DNA extraction and rtPCR. 
Post-enrichment DNA samples in BPW were extracted using the DNA extraction method 
described above for pure culture.  
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Sequencing of isolates with unexpected results 
Salmonella isolates that did not react as expected on the rtPCR (i.e., results did not match 
NVSL serotyping) were sequenced in the region amplified by the fljB primer set to determine the 
cause of the unexpected result. Sanger sequencing was completed at the ISU DNA Facility. The 
sequences were then assembled for further analysis using DNASTAR. BLAST analysis was 
subsequently used to compare the consensus sequences to known DNA sequences of S. 
Typhimurium and S. 4,[5],12:i:-. 
 
Validation using clinical samples (retrospective and prospective) 
Further validation of the rtPCR was done via retrospective and prospective analysis of 
clinical samples submitted to the ISU-VDL. For retrospective validation, porcine cases that met 
the following criteria were selected: 1) Salmonella was isolated from the sample submitted for 
culture, and 2) molecular testing was performed for identification of other disease entities on a 
sample from the same pig that had a Salmonella-positive culture. The use of samples that had 
molecular testing performed ensured that there was a DNA extract stored at -20°C from which 
further testing could be completed. The previously extracted DNA was tested via the Salmonella 
rtPCR as described above to compare to the results of culture. 
For prospective validation, feces, colonic mucosal scrapings, and fecal swabs rinsed in 1 
mL PBS were collected from pigs that had gross lesions suggestive of salmonellosis upon 
postmortem examination. These samples were subsequently tested for presence of Salmonella 
both directly and post BPW enrichment using the rtPCR. Other tissues from the large intestine 
were also collected for testing that included standard culture for Salmonella. Cultured isolates 
47 
 
 
from the standard testing were confirmed as Salmonella by the ISU-VDL and serotyped by the 
NVSL.  
 
Results 
Retrospective data analysis 
A total of 10,194 isolates of Salmonella were confirmed from swine clinical cases at the ISU-
VDL during 2008-2017. Of these, 3,476 of 10,194 (34%) of the isolates did not include the state 
of origin of the sample on the submission form. The remaining 6,718 of 10,194 (66%) of 
Salmonella isolates originated from farms in the following states: Iowa (45%); North Carolina 
(17%); Illinois (6%); Minnesota (5%); Arkansas, Kansas, Missouri, and Virginia (4% each); 
Nebraska and Pennsylvania (2% each); Arizona, California, Colorado, Hawaii, Idaho, Kentucky, 
Maryland, Massachusetts, Michigan, Montana, New Hampshire, New York, North Dakota, Ohio, 
Oklahoma, South Carolina, South Dakota, Texas, Utah, Wisconsin, and Wyoming (0.01-1% 
each). 
From 2008 to 2017, the number of S. 4,[5],12:i:- isolates identified from clinical cases in 
swine by the ISU-VDL rapidly increased, from a total of only 26 isolates between January 1, 
2008 through December 31, 2010, to 331 isolates identified in 2017 alone. During the same 
timeframe, isolation of S. Typhimurium decreased from 364 isolates in 2008 to 144 isolates in 
2017. In 2008, from a total of 1,060 isolates, the 5 Salmonella serovars most commonly isolated 
from swine through the ISU-VDL were (in order): Typhimurium (34%, serogroup B); Derby 
(13%, serogroup B); Choleraesuis (9%, serogroup C1); Agona (7%, serogroup B); and 
Heidelberg (6%, serogroup B). During 2008, Salmonella 4,[5],12:i:- was the 5th most commonly 
identified serogroup B isolate and the 13th most commonly isolated serovar overall, representing 
48 
 
 
<2% of all isolates of Salmonella from swine. In contrast, by 2017, the 5 most commonly 
isolated serovars, from among 1,031 total isolates, were (in order): 4,[5],12:i:- (32%); 
Typhimurium (14%); Derby (9%); Choleraesuis (7%); and Infantis (5%; serogroup C1). Thus, by 
2017, 32.1% of all Salmonella isolated from swine at the ISU-VDL were identified as 
Salmonella 4,[5],12:i:- . Additionally, S. 4,[5],12:i:- made up 50.3% of all Group B isolates (Fig. 
1). This observation coincided with a proportional decrease in identification of both S. 
Typhimurium (decreased from 34.3% in 2008 to only 14.0% of isolates in 2017) and all other 
Salmonella serogroup B serovars as well. Interestingly, the percentage of serogroup B isolates 
from porcine samples has remained relatively constant between 2008 and 2017, comprising 65% 
of 1,060 total porcine Salmonella isolates in 2008 and 64% of 1,031 total isolates in 2017. The 
tipping point in observed dominance between S. Typhimurium and S. 4,[5],12:i:- in swine 
occurred rapidly between 2013 and 2014, and the trend for increasing actual and relative 
frequency of isolation of Salmonella 4,[5],12:i from swine cases has remained constant since that 
time.  
 
Inclusivity and exclusivity of the rtPCR 
Results of the inclusivity study indicated that, of the 45 serovar-confirmed S. Typhimurium 
isolates tested, 44 were correctly identified as S. Typhimurium by the rtPCR assay based on a 
positive signal for all 4 genes tested (Supplementary Table 3). Of the 61 S. 4,[5],12:i:- isolates 
tested, 60 were correctly identified as matching the NVSL-confirmed serovar (4,[5],12:i:-) based 
on a positive signal for the invA and fliA genes and negative on either one or both of the hin-iroB 
or fljB targets given that one or both of which must be absent for the isolate to be considered 
monophasic. Isolates tested for exclusivity reacted as expected (Supplementary Table 2), with all 
49 
 
 
Salmonella isolates testing positive for the invA gene, negative for fliA gene, and variable results 
for the other 2 targets. All non-Salmonella fecal organisms tested for exclusivity also reacted as 
expected, being negative for all gene targets.  
Interestingly, the S. 4,[5],12:i:- isolates were consistently a minimum of 8 Ct values 
higher for the fljB target than the Ct value of the invA and fliA gene targets (Table 2). This trend 
was not noticed in the S. Typhimurium isolates. To determine the source of the differences in the 
Ct values of fljB, 5 S. Typhimurium and 5 S. 4,[5],12:i:- isolates were sequenced in the region 
amplified by the fljB primers which includes the 5’ coding region of the fljB gene. The fljB gene 
is 1,521 nucleotides, translating to 506 amino acids. Four base pairs were found to be 
consistently different between S. Typhimurium and S. 4,[5],12:i:- isolates (nucleotide 38: C to T; 
nucleotide 73: A to T; nucleotide 103: T to C; and nucleotide 163: C to T). The base pair 
differences did not result in any changes in the translated amino acid sequence. Additionally, the 
base pair differences were not located in the primer or probe binding sites, so it is unclear why 
the change results in differences in Ct values in the rtPCR assay. Several other Salmonella 
serovars tested on exclusivity testing also exhibited the same difference in Ct values between 
targets (Supplementary Table 2). 
For the 2 isolates tested for inclusivity that did not react as expected in the rtPCR, further 
sequencing was also performed (Supplementary Table 3). Isolate “A” was positive for all 4 
targets, but the fljB gene Ct value was >8 cycles greater than the invA and fliA genes. The Ct 
value difference would make the isolate appear to be a S. 4,[5],12:i:- isolate, which matches its 
identification by NVSL serotyping. However, given that the isolate was positive for all 4 genes 
by the rtPCR, identification as a S. Typhimurium isolate would also be expected. Isolate “B” was 
negative for hin-iroB but positive for the remaining 3 targets. Given that the isolate was negative 
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for hin-iroB, it would be expected to be a S. 4,[5],12:i:- isolate. However, the lack of a Ct 
difference between the fljB and invA/fliA genes would make the isolate more likely a S. 
Typhimurium, which matches its identification by NVSL serotyping. When the sequence of the 
target region amplified by the fljB primers was determined for both isolates, the identification 
based on the 4 base pair differences matched the NVSL serovar identification. 
 
Limit of detection and clinical validation of rtPCR 
The limit of detection was determined to be ~ 500 CFU/g (or mL) of feces tested directly 
without enrichment. When the same samples were enriched in BPW for 18-24 h prior to running 
the rtPCR, the limit of detection was 5 CFU/mL feces. The calculated R2 value for S. 
Typhimurium was 0.967 and for S. 4,[5],12:i:- was 0.964, indicating a strong inverse correlation 
between Ct values and CFU/mL (or g) of sample (Supplementary Fig. 1).  
Further clinical validation of the rtPCR was completed using both retrospective (no 
enrichment) and prospective (both direct and enrichment) samples from clinical cases at the ISU-
VDL (Table 3). All prospective samples (n = 24) were identified as the same by culture and 
rtPCR (both with and without enrichment). Specifically, 4 samples were identified as S. 
4,[5],12:i:- in both culture and rtPCR. Four samples were identified as Salmonella Heidelberg in 
culture and as non-Typhimurium, non-4,[5],12:i:- Salmonella in rtPCR. Sixteen of the samples 
were negative for Salmonella in culture and rtPCR. Although there were differences in the Ct 
values obtained from the non-enriched version and enriched version of each sample, the same 
conclusion was reached on all of the samples (data not shown). 
For the retrospective validation completed on previously extracted DNA, of the 42 
samples tested, 34 samples gave identical matches between the culture and rtPCR results. Four of 
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the samples contained very low levels of Salmonella organisms in culture with only a few 
Salmonella-suspect colonies noted on the original agar plates; all of these samples were negative 
for Salmonella by rtPCR. Of the 4 remaining samples, 2 had high Ct values on rtPCR (30-40) 
that would have led to an interpretation as positive for the presence of Salmonella DNA in the 
sample but inconclusive for identification at the serovar level; these samples were positive for S. 
4,[5],12:i:- by culture with only single-to-low colony growth present. The remaining 2 samples 
were classified as S. Typhimurium by rtPCR but as S. 4,[5],12:i:- by culture and serotyping. 
 
Discussion 
Our investigation of the most common serovars identified at the ISU-VDL clearly 
demonstrates that over the last several years, S. 4,[5],12:i:- has become the dominant Salmonella 
serovar isolated from clinical samples in swine at the ISU-VDL. This finding may have 
important implications for development of herd infection prevention strategies given that there 
are currently no vaccines labeled for control of infection with Salmonella 4,[5],12:i:- in swine in 
the United States. Additional research investigating the cause of the emergence of S. 4,[5],12:i:- 
is warranted based on our results.  
The fljB gene did not react as was expected based on the results from the original 
published validation.35 During our validation of the rtPCR, this gene was consistently 8-10 Ct 
cycles greater than that of the fliA and invA genes for all S. 4,[5],12:i:- isolates. Through 
sequencing of 5 S. Typhimurium and 5 S. 4,[5],12:i:- isolates, we noted that 4 base pairs were 
consistently different between the 2 serovars. However, none of the differences were in the 
primer or probe binding regions, and therefore, they do not help to explain this anomaly. It 
remains unknown why the difference was not observed in the original study.35 However, it is 
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possible that, because the isolates originated from Germany for the original validation, they 
possess different mutations or deletions that led to the monophasic phenotype compared to the 
isolates from the United States that we used. The isolates used in the prior study also originated 
from human, animal, food, and environmental sources rather than strictly from porcine samples 
as was the case in our study. It is also possible that in the original validation, samples were only 
weakly positive for Salmonella, resulting in Ct values for the fljB gene greater than the negative 
cutoff. However, based on the consistency of the results achieved in our study, the Ct value 
difference can be used as an identification aid in differentiating S. Typhimurium isolates from S. 
4,[5],12:i:- isolates. Although we do not believe that that this is a significant limitation to the 
assay based on the current knowledge of mutations that have led to the monophasic phenotype, it 
is possible that additional mutations exist and have yet to be characterized or will emerge that 
might interfere with identification utilizing our method. In addition, as all clones of S. 4,[5],12:i:- 
are at this time believed to originate from S. Typhimurium, at minimum all should still be 
identified as potentially pathogenic based on positivity of the invA and fliA genes via the rtPCR.  
Due to variability between Ct values of the gene targets, one of the limitations of our 
rtPCR assay is that samples could not be identified reliably at the serovar level by our rtPCR if 
the Ct values were >30. Slight differences in Ct cycles between invA, fliA, and hin-iroB, as well 
as fljB in non-S. 4,[5],12:i:- isolates, raises concerns that as the standard Ct cutoff value (40) for 
negative rtPCR tests is approached, it is possible that one of the targets will appear negative 
while others test positive. However, we mitigated this issue by using a BPW enrichment step 
prior to the rtPCR to increase the amount of Salmonella DNA present in the sample, thereby 
avoiding high Ct values and ensuring more accurate interpretation of results. Based on this 
limitation, although the rtPCR can be used directly on clinical samples such as feces, intestinal 
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contents, and intestinal scrapings, the more ideal approach is to utilize the rtPCR either following 
BPW enrichment or as a confirmatory step following standard culture. In our study, use of the 
BPW enrichment step prior to rtPCR appears to provide advantages for both increasing 
sensitivity by improving the limit of detection (from 500 CFU/mL to 5 CFU/mL) and improving 
specificity by ensuring that enough organism is present to generate Ct values less than <30. The 
lack of enrichment prior to DNA extraction in the retrospective case study highlights the 
sensitivity challenges with rtPCR when a low number of Salmonella are present in a sample. 
One additional potential limitation of our rtPCR applies to simultaneous infections by 
more than one serovar of Salmonella, which has been described in pigs and may in fact be 
commonplace.22 The identification of S. 4,[5],12:i:- by rtPCR is dependent on the fljB and/or hin-
iroB targets being negative. Therefore, if a pig had a co-infection with both S. 4,[5],12:i:- and a 
serovar that possessed those genes, the rtPCR results would be indistinguishable from a pig 
infected only with S. Typhimurium. We believe that the possibility of mixed infections may 
explain the difference between rtPCR identification and serotyping observed in 2 of the samples 
in the retrospective validation that was performed. The standard Salmonella culture protocol of 
the ISU-VDL includes pursuit of complete identification at the serovar level for only one isolate 
per sample. Thus, in the case of mixed infection, it is conceivable that the one serotyped isolate 
was not representative of the entire Salmonella population present in the original sample. While 
we do not at this time know the significance of mixed infections with S. Typhimurium and S. 
4,[5],12:i:- in swine, discordant results between NVSL serotyping and rtPCR results in clinical 
cases may warrant further investigation to determine if multiple serovars may be present in a 
clinical sample to better direct clinical decision making. Additional research studies have also 
demonstrated that some isolates of Salmonella may present phenotypically as monophasic 
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isolates, but still maintain a biphasic molecular status.4,10 Therefore, it is also possible that the 
few discordant results identified in our study may also be due to this phenomenon; further 
research into the reason for this is warranted. 
Although our rtPCR cannot replace antimicrobial susceptibility testing in selection of the 
proper antimicrobial agent, it can detect the presence of Salmonella in a sample and identify it to 
the serovar level for S. Typhimurium and S. 4,[5],12:i:-. This identification can be completed 
earlier than susceptibility data can be made available. Given that S. 4,[5],12:i:- tends to be a 
highly resistant organism when compared to S. Typhimurium,11 serovar identification provides 
additional information regarding the common antimicrobial resistance profile to aid in the earlier 
selection of an antimicrobial likely to be effective, which can minimize the overall effects of an 
outbreak in a herd. Recognized differences in common antimicrobial susceptibility patterns 
between the serovars may also provide cause for treatment failures in mixed infections.  
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Tables 
Table 1. Expected multiplex real-time PCR results for Salmonella enterica serovars 
Typhimurium and 4,[5],12,i:- compared to all other serovars based on presence or absence 
of target genes. 
* S. 4,[5],12:i:- can be negative for either hin-iroB, fljB, or both hin-iroB and fljB 
† If fljB has >8 threshold cycle (Ct) difference from fliA gene, then the isolate is likely S. 4,[5],12:i:-; if there is <5 
Ct difference, then the isolate is likely S. Typhimurium 
  
Gene 
target 
Interpretation 
Expected PCR Result 
Salmonella 
4,[5],12,i:- 
Salmonella 
Typhimurium 
Salmonella non-
Typhimurium, 
non-4,[5],12:i:- 
invA Present in all Salmonella Positive Positive Positive 
fliA 
Present in both 
Typhimurium and 
4,[5],12:i:- only 
Positive Positive Negative 
hin-iroB 
Always present in 
Typhimurium, may be 
absent in 4,[5],12:i:- and 
other serotypes 
*Positive or 
negative 
Positive 
Positive or 
negative 
fljB† 
Always present in 
Typhimurium, may be 
absent in 4,[5],12:i:- and 
other serotypes 
*Positive or 
negative 
Positive 
Positive or 
negative 
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Table 2. Primer and probe sequences utilized for the multiplex real-time PCR for 
differentiation of Salmonella Typhimurium and 4,[5],12:i:- serovars. 
Component Gene and sequence PCR product 
(bp) 
Reference 
invA 
Forward 
Primer 
CAT TTC TAT GTT CGT CAT TCC 
ATT ACC 
133 Pusterla et al.38 
Reverse 
Primer 
AGG AAA CGT TGA AAA ACT GAG 
GAT TCT 
Probe 56-FAM-TCT GGT TGA-ZEN-TTT 
CCT GAT CGC ACT GAA TAT C-
3IABkFQ 
fliA 
Forward 
Primer 
CAT TAC ACC TTC AGC GGT AT 
254 Maurischat et al.35 
Reverse 
Primer 
CTG GTA AGA GAG CCT TAT AGG 
Probe 5Cy55-CGG CAT GAT TAT CCG TTT 
CTA CAG GG-3IAbRQSp 
hin-iroB 
Forward 
Primer 
GTG TGG CAT AAA TAA ACC GA 
274 Maurischat et al.35 
Reverse 
Primer 
AGG CTT ACC TGT GTC ATC CA 
Probe 5Hex-TAA CGC GCT-ZEN-CAC GAT 
AAG GC-3IABkFQ 
fljB 
Forward 
Primer 
TGG TGC TGT TAG CAG AC 
297 Maurischat et al.35 
Reverse 
Primer 
TCA ACA CTA ACA GTC TGT CG 
Probe 5TexRd-XN-AAC CGC CAG TTC ACG 
CAC-3IAbRQSp 
IAC (XIPC695) 
Forward 
Primer 
TTC GGC GTG TTA TGC TAA CTT C 
NA 
ISU-VDL internal 
control Reverse 
Primer 
GGG CTC CCG CTT GAC AAT A 
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Probe 5Cy5-CTC CGC AGA-TAO-AAT CCA 
GGG TCA CG-3IAbRQSp 
IAC = internal amplification control; bp = base pairs 
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Table 3. Results of real time PCR exclusivity testing to ensure no cross reactivity of non-
Typhimurium, non-4,[5],12:i:- serovars of Salmonella or other non-Salmonella organisms 
commonly found in feces. 
Serotype n invA fliA hin-irob fljB 
S. Agona 2 + - - - 
S. Derby 2 + - - - 
S. Heidelberg 2 + - + + 
S. Infantis 2 + - + + 
S. Johannesberg 2 + - - + 
S. Anatum* 2 + - + + 
S. Seftenberg 2 + - - - 
S. Worthington* 2 + - + + 
S. Ohio* 2 + - + + 
S. Mbandaka* 2 + - + + 
S. Muenchen* 1 + - + + 
S. Brandenburg 1 + - - + 
S. Give 1 + - - + 
S. Havana 1 + - - - 
S. 6,7:Nonmotile 1 + - + + 
S. Saintpaul 1 + - + + 
S. Kiambu 1 + - + + 
S. Bovismorbidificans 1 + - - + 
S. Krefeld* 1 + - + + 
S. Litchfield 1 + - + + 
S. Liverpool 1 + - + + 
S. Cerro 1 + - - - 
S. London 1 + - + + 
S. Schwarzengrund 1 + - - + 
S. Risen 1 + - - - 
S. Newport* 1 + - + + 
S. Choleraesuis var kunzendorf 1 + - + + 
S. Uganda* 1 + - + + 
E. coli 1 - - - - 
Citrobacter freundii 1 - - - - 
Klebsiella pneumoniae 1 - - - - 
Enterobacter sp. 1 - - - - 
Enterococcus faecium 1 - - - - 
Streptococcus suis 1 - - - - 
Proteus mirabilis 1 - - - - 
* Ct value was >8 more than Ct value of fliA and invA, similar to the findings with S. 4,[5]12:i:- 
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Table 4. Results of real time PCR inclusivity testing of Salmonella Typhimurium and 
4,[5],12:i:- isolates to ensure correct identification of serovar compared to traditional 
serotyping. 
Serovar n invA fliA hin-iroB fljB 
Salmonella 4,[5],12:i:- 61 + + - +* 
Salmonella. Typhimurium 45 + + + + 
Isolate A (S. 4,[5],12:i:-) 1 + + + +* 
Isolate B (S. Typhimurium) 1 + + - + 
*Denotes that cycle threshold (Ct) value was >8 more than Ct value of fliA and invA  
 
Table 5. Representative example of real time PCR results, expressed as cycle threshold (Ct) 
values, for pure culture of 4 different Salmonella serovars including S. Typhimurium and 
S. 4,[5],12:i:-.  
Serovar 
Representative example of Ct values for each gene target 
invA fliA hin-iroB fljB 
S. 4,[5],12:i:- 22.98 24.62 Negative 35.2 
S. Typhimurium 21.27 21.32 23.18 21.9 
S. Agona 18.55 Negative Negative Negative 
S. London 18.32 Negative 18.4 20.9 
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Table 6. Results of prospective and retrospective validation of the multiplex real time PCR 
completed directly on clinical samples and compared to NVSL serotyping results. 
n 
Identification 
Culture result rtPCR result 
Prospective Validation 
4 S. 4,[5],12:i:- S. 4,[5],12:i:- 
4 S. Heidelberg  Salmonella, non-Typhimurium, 
non-4,[5],12:i:- 
16 No Salmonella No Salmonella 
Retrospective Validation 
16 S. 4,[5],12:i:- S. 4,[5],12:i:- 
5 S. Typhimurium S. Typhimurium 
13  Salmonella, non-Typhimurium, 
non-4,[5],12:i:- 
 Salmonella, non-Typhimurium, 
non-4,[5],12:i:- 
3 S. 4,[5],12:i:-* Negative  
1 Salmonella, non-Typhimurium, 
non-4,[5],12:i:-* 
Negative  
2 S. 4,[5],12:i:-* Inconclusive† 
2 S. 4,[5],12:i:- S. Typhimurium 
* Few colonies to low levels of Salmonella spp. growth in culture 
†Results would have been interpreted as “Inconclusive” due to high cycle threshold (Ct) values >30 
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Figures 
 
Figure 1. The percent contribution of Salmonella Typhimurium and 4,[5],12:i:- to the 
serogroup B Salmonella isolates of Salmonella identified from swine clinical cases at the Iowa 
State Veterinary Diagnostic Laboratory from 2008-2017.  
 
Legend 
 Serogroup B Salmonella, non-Typhimurium, non-4,[5],12:i:- 
  Salmonella 4,[5],12:i:- 
  Salmonella Typhimurium  
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Figure 2. Determination of the limit of detection of the fliA probe of the multiplex real time 
PCR assay compared to standard plate counts to identify Salmonella Typhimurium and 
Salmonella 4,[5],12:i:- following inoculation into Salmonella-negative feces. 
Legend 
  Salmonella 4,[5],12:i:- 
  Salmonella Typhimurium 
  Salmonella 4,[5],12:i:- trend line 
  Salmonella Typhimurium trend line  
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Abstract 
Over the past 5 years, identification of Salmonella 4,[5],12:i:- in swine samples submitted 
to veterinary diagnostic laboratories in the United States has increased substantially while 
identification of Salmonella Typhimurium has concurrently decreased. The overall goal of this 
study was to facilitate a better understanding of the significance of increasing identification of 
this emerging serovar. To compare the pathogenicity of S. 4,[5],12:i:- in swine to the known 
pathogenic S. Typhimurium and lesser pathogenic S. Derby, 72 pigs (20 per Salmonella serovar 
treatment and 12 controls) were inoculated with either Salmonella Typhimurium, Salmonella 
4,[5],12:i:-, Salmonella Derby or sham-inoculated and followed for up to 28 days after 
inoculation. To compare the competitive fitness of S. 4,[5],12:i:- to S. Typhimurium in swine 
when co-infected, a second animal study utilizing 12 pigs co-inoculated with equal 
concentrations of both Salmonella Typhimurium and Salmonella 4,[5],12:i was performed.. The 
results clearly demonstrate that Salmonella serovar 4,[5],12:i:- possesses similar ability as 
Salmonella Typhimurium to cause significant clinical disease in swine and can be carried in the 
tonsils and ileocecal lymph nodes and shed in the feces of infected animals for weeks following 
exposure and illness. Additionally, when co-inoculated, 4,[5],12:i:- was consistently detected in 
the feces of a higher percentage of pigs and at higher levels than Typhimurium. This finding 
indicates that serovar 4,[5],12:i:- may have an improved competitive fitness relative to serovar 
Typhimurium when inoculated simultaneously into naïve pigs, which may suggest a mechanism 
for the increasing identification of Salmonella 4,[5],12:i:- in swine diagnostic samples over the 
past several years worldwide.  
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Introduction 
Salmonella infections in swine, known as salmonellosis, can cause septicemia, 
enterocolitis, or subclinical infections1,2. The septicemic form is often caused by S. Choleraesuis 
and generally has high mortality, low morbidity, and signs including anorexia, fever, lethargy, 
and dyspnea1. The enterocolitic form has historically been associated with S. Typhimurium and 
generally has low mortality, high morbidity, and signs including anorexia, fever, lethargy, and 
diarrhea1. The subclinical form of salmonellosis does not cause overt signs of disease but may be 
associated with reduced productivity and average daily gain3 in addition to increasing the risk of 
contamination of the final product during harvest thereby presenting a food safety concern. 
 With the characteristics of infection and outcome determined partly by the infecting 
serovar, a more thorough understanding of the pathogenesis of disease caused by highly 
prevalent serovars can aid in understanding the expected course of disease and appropriate 
control measures. In previous years, S. Typhimurium was the most commonly reported serovar 
in humans and swine4,5. More recently, however, S. 4,[5],12:i:- has been increasingly identified 
worldwide in humans, swine, cattle, and poultry5-7. In fact, S. 4,[5],12:i:- has been documented to 
be more common than S. Typhimurium in the US swine population based on data from the 
National Veterinary Services Laboratory (NVSL) and the Iowa State University (ISU) 
Veterinary Diagnostic Laboratory (VDL) since 20146 (see also CHAPTER 2). Although S. 
4,[5],12:i:- has been reported more frequently, additional research needs done to evaluate the 
specifics of its disease-causing ability in swine. Based on published research using multiple-
locus variable number tandem repeat analysis (MLVA), phage typing, pulsed-field gel 
electrophoresis (PFGE), and polymerase chain reaction (PCR), it is highly likely that S. 
4,[5],12:i:- is a monophasic variant of S. Typhimurium8-15. Thus, S. 4,[5],12:i:- could resemble 
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the disease-causing ability of S. Typhimurium. However, the required involvement of flagella in 
the pathogenesis of Salmonella raises the concern that, with only one phase of flagellar antigens 
being expressed, S. 4,[5],12:i:- may have an impaired ability to infect swine and cause disease16-
18.  
Only two studies have been published to date on the pathogenesis and severity of disease 
caused by S. 4,[5],12:i:- infections in swine, and of those studies, contradictory findings have 
been reported. One study determined that S. 4,[5],12:i:- does not induce a fever following 
experimental infection of 7-week old pigs19 while the other reported that a significant increase in 
rectal temperature occurs by the second day post infection (DPI)20. In the first study, S. 
Typhimurium and S. 4,[5],12:i:- were both reported as being capable of causing diarrhea in 
weaned pigs, and although the timing of the diarrhea varied with serovar, both serovars caused 
diarrhea seven or more days following inoculation19. This is also in contrast to the second study 
which reported that S. 4,[5],12:i:- infection of swine led to diarrhea by DPI 220. Neither study 
assessed the gross or histologic pathology associated with inoculation of S. 4,[5],12:i:- in swine, 
although a retrospective study found that identification of S. 4,[5],12:i:- from clinical specimens 
was associated with histopathologic evidence of disease21. While little is known about S. 
4,[5],12:i:-, the literature is much more clear on the fact that S. Typhimurium is considered to be 
pathogenic in swine while other common serovars such as S. Derby are not know to display 
significant pathogenicity despite frequent isolation19,21,22. Given the differences in the 
presentation of salmonellosis based on the infecting serovar as well as inter-study differences, 
more work is needed, with larger sample sizes of pigs and various stages of growth to better 
determine the effect of S. 4,[5],12:i:- infection in swine, particularly when compared to other 
serovars with known levels of pathogenicity. 
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The ability to colonize tissues throughout the pig has also been shown to differ by 
serovar. While S. Typhimurium is able to colonize the ileum, ileocecal lymph nodes, tonsils, and 
mandibular lymph nodes, other serovars such as S. Rissen and S. Anatum have been shown to 
colonize a smaller subset of those tissues23. However, S. Typhimurium is less able to colonize 
non-enteric viscera (liver, spleen, lung) and skeletal muscles when compared to intestines, colon, 
tonsils, and mesenteric lymph nodes24. Similarly, mesenteric lymph nodes collected from swine 
at the time of slaughter proved to be frequently positive for Salmonella of various serovars, 
including S. 4,[5],12:i:-, although they were predominantly positive for S. Typhimurium25,26. It 
remains unclear based on this study whether the observed difference in prevalence of serovars in 
the mesenteric lymph nodes of swine was due to variations in the prevalence of serovars 
infecting swine or in the ability of each of the serovars to colonize tissues throughout swine. 
Following experimental infections with S. 4,[5],12:i:-, the tonsils, ileocecal lymph nodes, cecal 
mucosa, and Peyer’s patches were all colonized with Salmonella on 7 DPI in one study20 while 
the tonsils, mesenteric lymph nodes, and intestinal tissues were observed to be colonized with 
Salmonella on 21 and 49 DPI in another study19. Due to the strong correlation between 
colonization of various tissues of swine at the time of slaughter and increased risk of 
contamination of the carcass23, it is necessary to understand the colonization potential of each 
serovar and the role of host factors to fully understand the potential risks from Salmonella 
infections.  
Yet another risk associated with Salmonella infections of swine is the potential for 
persistence of the organism, with subsequent transmission to other pigs or contamination of their 
environment through shedding in feces27-29. With Salmonella transmission occurring primarily 
through the fecal-oral route, an improved awareness of the expected shedding pattern would also 
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facilitate appropriate interpretation of fecal culture results and understanding of the course of 
infection. Many serovars have been documented to cause persistent infections in swine as 
evidenced by prolonged fecal shedding, including Typhimurium, Derby, Yoruba, and 
Cubana30,31, although the duration of persistence varies with serovar, infecting dose, and host-
specific factors2,30. In pigs naturally infected with various serovars of Salmonella, fecal shedding 
was highly variable on an individual pig basis in terms of both the pattern and amount of 
shedding2. Only one study has been completed to evaluate the persistence of S. 4,[5],12:i:- in 
swine following a known infection event. Salmonella 4,[5],12:i:- has been detected in the feces 
of all four swine 49 days after infection with S. 4,[5],12:i:-19, indicating the potential to cause 
persistent infections although more work is needed given that only four pigs were maintained in 
that study until DPI 49.  
The rise in prevalence of Salmonella 4,[5],12:i:- in livestock and humans also raises the 
question of why the serovar has recently emerged and become increasingly prevalent. 
Salmonella 4,[5],12:i:- has repeatedly been reported to be more highly resistant to antimicrobials 
relative to S. Typhimurium7,32,33, which may provide a significant advantage to its survival in 
swine operations with extensive antimicrobial drug use. Likewise, S. 4,[5],12:i:- is commonly 
resistant to heavy metals such as zinc and copper, which can be added to livestock feeds as an 
alternative to antimicrobial drugs to reduce bacterial infections15,34. With the antimicrobial 
properties of some heavy metals, it is evident why resistance to them would provide a selective 
advantage over more susceptible serovars. Another potential mechanism leading to the 
emergence of the S. 4,[5],12:i:- serovar is the ability to outcompete other serovars in vivo. 
Salmonella 4,[5],12:i:-, despite lacking one phase of flagellar antigens, has retained its ability to 
adhere to and invade porcine intestinal epithelial cells in vitro35. Additionally, a study of 133 
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monophasic isolates showed that the majority possessed the ability to form biofilms36; this could 
enhance the survivability while reducing the effects of antimicrobials on the bacteria36,37. 
Salmonella 4,[5],12:i:- also commonly possesses multiple virulence genes that may contribute to 
its survival within the host and environment; these genes include but are not limited to sipC 
which is involved in cell adhesion and invasion, sopB which is involved in the intestinal changes 
that lead to diarrhea, and hilA which activates the invasion process38. The combination of biofilm 
formation, presence of virulence genes involved in the pathogenesis, resistance to antimicrobials, 
and resistance to heavy metals may all function together to provide a selective and competitive 
advantage to S. 4,[5],12:i:-.  
Based on the limited data available, we hypothesized that Salmonella 4,[5],12:i:- 
possesses abilities similar to that of S. Typhimurium and greater than that of S. Derby in regards 
to disease-causing ability, colonization, and persistence in swine. We also hypothesized that S. 
4,[5],12:i:- displays a competitive advantage in colonization over S. Typhimurium to allow the 
monophasic serovar to predominate in swine. To address some of the gaps in knowledge related 
to these hypotheses, three separate animal studies were performed with the goal of answering the 
following questions: 1) determine the clinical course of disease caused by S. Typhimurium, S. 
4,[5],12:i:-, and S. Derby relative to uninfected pigs; 2) compare the ability of the three serovars 
to colonize tissues throughout the pig; 3) evaluate the persistence of the three serovars in swine 
over time; and 4) compare the ability of S. 4,[5],12:i:- to outcompete S. Typhimurium in co-
inoculated pigs.  
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Materials and Methods 
Salmonella isolate selection 
Salmonella enterica serovars Typhimurium, 4,[5],12:i:-, and Derby isolates were selected 
from the collection of clinical isolates submitted to the Iowa State University (ISU) Veterinary 
Diagnostic Laboratory (VDL). These isolates were originally cultured from clinical samples 
submitted to the ISU-VDL using standard laboratory protocols (see CHAPTER 2). Serotyping 
was completed by the National Veterinary Services Laboratory (NVSL). Selection of isolates for 
all studies was based on the following criteria: 1) isolation from clinical samples submitted to the 
ISU-VDL, 2) originate from 3-13 week old pigs, and 3) association with histopathologic lesions 
suggestive of salmonellosis. For the pathogenesis study (animal study #2), an isolate of S. 
Typhimurium that had previously been used in a successful animal study (ISU-VDL, 
unpublished data) that met all of the criteria above was selected to be used. To ensure 
identification of an appropriate clinical isolate of Salmonella 4,[5],12:i:- that had retained its 
virulence following laboratory passage, a small scale preliminary study was performed using 
three separate isolates of 4,[5],12:i:- meeting the above criteria (animal study #1). For the 
competitive fitness animal study (animal study #3), clinical isolates of S. Typhimurium and S. 
4,[5],12:i:- that met the above criteria and exhibited complimentary resistance profiles (S. 
4,[5],12:i:- isolate susceptible to ceftiofur but resistant to gentamicin; S. Typhimurium isolate 
susceptible to gentamicin but resistant to ceftiofur) were utilized for this study. Antimicrobial 
susceptibility testing was completed using the TREK Sensititre™ system and Sensititre™ 
Bovine/Porcine MIC Plate (ThermoFisher Scientific, Catalog #BOPO6F) according to Clinical 
and Laboratory Standards Institute (CLSI) guidelines in the VET08 document. Ceftiofur has a 
veterinary-specific swine breakpoint for respiratory disease pathogens only (Streptococcus suis, 
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Actinobacillus pleuropneumoniae, and Pasteurella multocida) from which the breakpoint for 
Enterobacteriaceae is currently extrapolated. Gentamicin has human Enterobacteriaceae 
breakpoints that can be utilized to guide breakpoint determinations in swine. Based on the human 
and veterinary breakpoints available for these antimicrobials, extrapolated breakpoints were used 
to determine susceptibility, intermediate, and resistance for the antibiotics of interest on the 
Sensititre™ Bovine/Porcine MIC Plate. 
 
General culture conditions, inoculum preparation, and sample culture  
Salmonella isolates from clinical cases submitted to the ISU-VDL were stored in brain 
heart infusion (BHI) broth with 20% glycerin at -80°C. Isolates were removed from the freezer, 
sub-cultured onto tryptic soy agar with 5% sheep blood (Remel Products, Lenexa, KS), and 
incubated for 18-24 hours at 35°C. Plates were evaluated for purity of culture prior to use.  
 
Inoculum preparation for in vivo studies 
Once pure cultures were obtained, colonies of Salmonella were added to Mueller Hinton 
(MH) broth (BD Diagnostics, Sparks, MD). Based on quantitative Salmonella culture completed 
previously to determine the correlation between the optical density and CFUs of Salmonella, a 
target optical density (OD600) of 0.09 would approximately correlate to 1x108 CFU/mL; this 
was the goal of the inoculum. Once the inoculum was prepared, serial dilutions of the inoculum 
were plated to Tryptic Soy Agar with 5% sheep blood (Remel Products) to determine the actual 
concentration of Salmonella, and the remaining inoculum was stored in the refrigerator until 
administered to the piglets.  
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Salmonella detection and quantification  
Fecal and tissue samples were collected during the animal studies for culture using both 
quantitative and enrichment techniques. All samples collected for culture, including feces 
throughout the trial and tissues from necropsy, were stored in the refrigerator (4˚C) immediately 
following collection and were then transferred to the freezer (-80˚C) within 5 hours of collection 
until further processing could be completed.  
Samples collected for quantification of Salmonella were thawed at 37˚C until they 
reached room temperature, weighed, and added to Phosphate Buffered Saline (PBS) (Fisher 
Scientific, Rochester, MN) to create a 1:10 dilution of each sample. Tissue samples were further 
ground with a mortar-and-pestle type grinder to facilitate pipetting of samples. Serial dilutions 
were plated to Xylose-Tergitol-Lysine-4 (XLT4) agar (Remel Products) and then incubated at 
35°C without CO2. Colonies with morphology characteristic of Salmonella were counted daily 
for three days. Interpretation of standard plate count results used the following criteria: 1) 
quantification at day three was used to calculate concentration in the original sample unless 
plates were overgrown with normal flora at day three in which case counts from previous days 
were used to calculate concentrations; 2) plates with 25-250 colonies were considered reliably 
countable and 3) counts were averaged if more than one plate was in the countable range. 
Samples that had Salmonella detected by quantitative culture but below the countable level of 
25-250 colonies were listed as 750 CFU/mL. Samples that had Salmonella detected by 
enrichment culture but not from quantitative culture were listed as 500 CFU/mL. A minimum of 
one characteristic and representative colony per sample per pig was confirmed as Salmonella 
using Matrix Assisted Laser Desorption Ionization-Time of Flight-Mass Spectrometry (MALDI-
TOF-MS) following manufacturer’s recommendations (Bruker Daltonic Inc., Billerica, MA). Per 
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ISU-VDL protocol, a minimum MALDI-TOF-MS confidence score of 2.10 was required for a 
confirmatory genus level identification.  
In addition to quantification by serial dilutions, 0.25 mL of 1:10 dilution of each sample 
was enriched in 5 mL of Buffered Peptone Water (BPW) (Remel Products). The BPW was 
incubated for 18-24 hours at 35°C without CO2 prior to subculture to Brilliant Green agar with 
Novobiocin (BGN) (BD Diagnostics; Sigma-Aldrich, St. Louis, MO) and XLT4 agar. The BGN 
and XLT4 agars were incubated at 35°C without CO2 for 48 hours and were observed for 
colonies with morphology characteristic of Salmonella. A minimum of one colony from 
enrichment subculture per sample was confirmed as Salmonella using MALDI-TOF-MS. 
For isolation and identification of each serovar of Salmonella following co-inoculation of 
both Typhimurium and 4,[5],12:i:- from samples in animal study #3, Salmonella quantification 
was performed via standard plate counts on XLT4 supplemented with either ceftiofur or 
gentamicin [3 types of XLT4 agar: 1) XLT4 agar with gentamicin sulfate (VetOne, Boise, ID) at 
a concentration of 8 ug/mL to inhibit growth of S. Typhimurium, 2) XLT4 agar with ceftiofur in 
the form of Naxcel® (Zoetis, Parsippany, NJ) at a concentration of 0.5 ug/mL to inhibit growth 
of S. 4,[5],12:i:-, and 3) XLT4 without additional antibiotics]. To ensure the plates were 
inhibitive to the expected serovar, 1-2 representative colonies were confirmed as Salmonella by 
MALDI-TOF-MS and then were identified at the serovar level using PCR (see CHAPTER 2). 
 
Animal studies 
General information  
All studies involving animals were approved by the Iowa State University Institutional 
Animal Care and Use Committee (IACUC) prior to initiation (11-16-8391-S). All swine used in 
77 
 
 
the studies were five weeks of age at the initiation of the study; this age was selected based on 
evaluation of the most common age of animals positive for 4,[5],12:i:- from diagnostic samples 
from pigs with diarrhea and histologic lesions consistent with salmonellosis submitted to the 
ISU-VDL over the past several years as well as successful induction of disease with other 
serovars of Salmonella in this age group27,39,40. All animals were pre-screened as negative for 
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Porcine Epidemic 
Diarrhea Virus (PEDV) via pooled polymerase chain reaction (PCR) testing as well as 
Salmonella negative status via individual enrichment fecal culture and/or enriched PCR prior to 
initiation of the study. The pigs were acclimated for 72 hours following arrival prior to 
inoculation during which time baseline weights, temperatures, and fecal scores were recorded 
and pre-inoculation fecal swabs were obtained. Pigs were randomly assigned to treatment 
groups, and each treatment group was housed in separate biosecure rooms for the duration of 
each study. Throughout the acclimation and study periods, all pigs were fed a complete diet of 
non-medicated corn and soybean meal except for the 12 hours prior to inoculation during which 
all pigs were held off feed. All pigs were euthanized using barbiturate overdose. 
 
Scoring systems: fecal consistency, gross pathology, and histopathology 
Fecal scoring was standardized across all trials on a scale of 1-5 (1 = dry feces, 2 = moist 
feces, 3 = mild diarrhea, 4 = severe diarrhea, and 5 = watery diarrhea) as previously described41. 
This scoring system is depicted in Figure 1. Fecal scores of 1 and 2 were both considered to be 
normal scores, with a score of 2.5 or above indicating the presence of diarrhea. Pigs were 
diagnosed with clinical disease when the fecal score was 3 or above and/or rectal temperature 
outside of the normal range of 101.5-103.5˚F.  
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Gross necropsy scoring was completed on animals across all trials in a standardized 
manner. The severity and distribution of gross lesions were observed along the intestinal tract, 
with the entire intestinal tract length opened and evaluated for the presence of fibrinous exudate 
and necrotic portions. Samples collected at time of necropsy for histopathologic evaluation were 
placed in 10% neutral buffered formalin and included the following: liver; spleen; ileocecal 
lymph nodes; proximal, middle, and distal jejunum; ileum; cecum; middle and apex of spiral 
colon; and rectum. Histologic evaluation was performed at the ISU-VDL by a pathologist who 
was blinded to the pig numbers and treatment groups. The histologic evaluation protocol is 
summarized in Table 1. The ileocecal lymph node, spleen, and liver were evaluated for the 
presence or absence of neutrophils in 5-400X fields of view. These tissues were scored on a scale 
of 1-6 (1=neutrophils absent in all views, 6=neutrophils present in all views). The mean 
neutrophil count from 5-400X fields of view was determined for each small and large intestine 
sample. Any view with more than 100 neutrophils was considered “too numerous to count” and 
listed as 100 for averaging purposes. For large intestine samples, the mean was obtained of three 
crypt depths per section measured at 10X. Lastly, an ulceration score was determined for each 
small and large intestine sample. The ulceration score was equal to the number of crypts over 
which the most severe foci extended. This score ranged from 0 to 5, with 0 indicating a lack of 
observed ulceration and 5 indicating an ulcer spanning 5 or more crypts. 
A scoring system was derived to obtain an overall score of the histopathology data to 
facilitate comparison between sections of intestine. For a mean neutrophil count of less than 5, 0 
points were assigned. For every increase by 10 neutrophils, one additional point was assigned 
(i.e. 1 point for 5-10 neutrophils, 2 points for 11-20 neutrophils, 3 points for 21-30 neutrophils, 
etc.). Ulceration scores translated directly as points to the overall score (i.e. ulceration score of 2 
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added 2 points to the overall score). For crypt depths, the scoring system was as follows: <700 
um = 0 points, 700-800 um = 1 point, 800-900 um = 2 points, 900-1000 = 3 points, >1000 um = 
4 points). The crypt depth score was shifted to the right by 100 um for the rectum due to longer 
crypts in health (i.e. <800 = 0 points, 800-900 = 1 point, etc.). One additional point was added if 
evidence of submucosal inflammation was noted. Another point was added if crypt abscesses 
were observed.  
 
Animal study #1: Preliminary evaluation of pathogenicity of Salmonella 4,[5],12:i-  
To identify an appropriate clinical isolate of Salmonella 4,[5],12:i:- that had retained its 
pathogenic ability following laboratory passage, a small scale pilot study was performed using 
three separate isolates of 4,[5],12:i:-, isolates ISU-SAL0239-15 (A), ISU-SAL0240-15 (B), and 
ISU-SAL0241-16 (C), meeting the above criteria. A total of nine five-week old pigs were 
individually identified and randomly assigned to one of three treatment groups with three pigs 
per isolate. Each group was then orally inoculated with 10 mL of approximately 5 x 108 CFU/mL 
Salmonella inoculum with one of the three clinical isolates of S. 4,[5],12:i:-. The actual 
concentration of the inoculum was 5.3 x 107 CFU/mL, 6.9 x 107 CFU/mL, and 8.6 x 107 
CFU/mL for S. 4,[5],12:i:- isolates ISU-SAL0239-15 (A), ISU-SAL0240-15 (B), and ISU-
SAL0241-16 (C), respectively. The course of clinical disease as indicated by rectal temperature, 
fecal scoring, fecal Salmonella quantification was then followed for seven days. After seven 
days, the animals were euthanized and necropsies were performed to evaluate for gross and 
histopathologic signs of disease. Tissue samples collected at necropsy for Salmonella 
quantification included liver, spleen, tonsils, and ileocecal lymph nodes. The results of this study 
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were utilized to select an isolate of S. 4,[5],12:i:- to optimize the results of the large-scale animal 
study presented below. 
 
Animal study #2: Pathogenicity of Salmonella Typhimurium, 4,[5],12:i:-, and Derby 
in swine 
To determine the ability of Salmonella serovar 4,[5],12:i:- to cause disease and establish 
a carrier state in swine, 72 five-week old pigs were utilized in a month-long study examining the 
effect and duration of infection with 4,[5],12:i:- when compared to the known highly pathogenic 
serovar Typhimurium and lesser pathogenic serovar Derby. The pigs were individually identified 
and randomly assigned to the following treatments: 1) 20 pigs received oral inoculation with 
4,[5],12:i:- only (isolate ISU-SAL240-15), 2) 20 pigs received oral inoculation with 
Typhimurium only (isolate ISU-SAL243-14), 3) 20 pigs received oral inoculation with Derby 
only (isolate ISU-SAL242-16), and 4) 12 sham-inoculated pigs to serve as negative control. The 
pigs were housed in pens of four, with five total groups per treatment and three for the control 
group. The groups for each serovar were housed in separate rooms to ensure no cross 
contamination between treatments would occur. 
Following acclimation, the pigs were inoculated with a standardized dose for all 
serotypes of 10 mL of 1 x 108 CFU/mL Salmonella utilizing a combination of 8 mL oral gavage 
and 2 mL swabbed directly in the back of the mouth ensuring tonsil exposure as occurs during 
natural infection with Salmonella. The actual inoculum concentrations were 1.44 x 108 CFU/mL, 
1.53 x 108 CFU/mL, and 1.94 x 108 CFU/mL for S. 4,[5],12:i:-, S. Derby, and S. Typhimurium, 
respectively. Daily fecal scores were taken on all animals for the first seven days to monitor 
progression of clinical disease; as overt clinical disease was expected to decrease after the first 
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week of infection, bi-weekly fecal scores were taken for the remainder of the study. All pigs had 
rectal temperatures recorded for the first seven days and bi-weekly thereafter for the remainder 
of the study. Fecal samples were collected from the rectum of all pigs at 2 DPI, and all pigs still 
alive at DPI 4, 7, 14, 21 and 28 for quantitative and enriched Salmonella fecal culture to 
determine the amount of shedding of Salmonella into the environment over time following 
infection. 
On DPI 2 and 4, five pigs per treatment group and three control pigs were assigned to be 
euthanized for tissue collection based on severity of clinical signs (i.e. Salmonella-infected pigs 
demonstrating the most severe clinical signs based on a combination of rectal temperature and 
fecal score). The remaining pigs after day 4 (10 per experimental group; 6 in control group) were 
allowed to complete the study and were euthanized for sample collection at 28 DPI. At the time 
of euthanasia, evaluation of gross lesions was completed and samples were collected for 
histopathologic evaluation of the jejunum, ileum, cecum, colon, ileocecal lymph nodes, tonsils, 
liver, and spleen to evaluate the progression of clinical disease over time. Additional tissue 
samples, including ileocecal lymph nodes, tonsils, liver, spleen, and colon contents, were 
collected at the time of necropsy for quantitative Salmonella culture to assess the level of 
Salmonella colonization in these tissues at various points over time following inoculation.  
Two pigs were removed from this study. One pig was in the S. Derby group and was 
removed from the study due to premature death on DPI 2. The pig was submitted to the ISU 
VDL and determined to have died from a vitamin E-selenium responsive nutritional 
cardiomyopathy, better known as Mulberry Heart Disease. The other pig removed from the study 
was among the control group pigs euthanized on DPI 2 and was removed from the study due to 
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the presence of Isospora suis, a primary pathogen of swine, detected during histopathologic 
evaluation. All other animals completed the study and were included in the analysis. 
 
Animal study #3: Competitive fitness of Salmonella Typhimurium and 4,[5],12:i:- in 
swine 
To determine if Salmonella 4,[5],12:i:- has the ability to outcompete other pathogenic 
serovars of Salmonella, such as Typhimurium, in vivo, 12 five-week old pigs were co-inoculated 
with a 50:50 mixture of the two serovars. Six additional pigs, three for S. Typhimurium and three 
for S. 4,[5],12:i:-, were singly inoculated for a controlled comparison. The isolates used for the 
study were Salmonella 4,[5],12:i:- ISU-SAL245-16 and Salmonella Typhimurium ISU-SAL244-
16. The co-inoculated pigs were housed in pens of four, with three total groups in a single room, 
while each of the singly inoculated groups were housed in a single pen of three each in separate 
rooms. Following acclimation, the pigs were inoculated with a standardized dose of 10 mL of 1 x 
108 CFU/mL Salmonella utilizing combination of 8 mL oral gavage and 2 mL swabbed directly 
in the back of the mouth for each serovar, for a total of 20 mL for co-inoculated and 10 mL for 
singly inoculated animals. The actual inoculum concentrations were 1.38 x 108 CFU/mL and 
1.73 x 108 CFU/mL for S. Typhimurium and S. 4,[5],12:i:-, respectively. Following inoculation, 
daily rectal temperatures and fecal scores were taken on all animals for the first seven days to 
monitor progression of clinical disease; bi-weekly temperatures and fecal scores were taken for 
the remainder of the study. Fecal samples were collected from all pigs alive on DPI 1-5, 7 and 10 
for quantitative culture of both serovars of Salmonella.  
One pig that was inoculated with both S. Typhimurium and S. 4,[5],12:i:- died on DPI 3. 
This pig was submitted for evaluation at the ISU VDL following the same protocol as described 
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for the study. It was determined that the pig had developed septicemia with both Salmonella 
serovars as the ileum, colon, liver, spleen, tonsils, and ileocecal lymph nodes were all culture 
positive for Salmonella. One additional pig was euthanized on DPI 6 due to neurologic deficits, 
severe fever, and deteriorating condition. This pig was also submitted for evaluation at the ISU 
VDL, and was determined to have meningoencephalitis caused by Haemophilus parasuis. Both 
of these pigs were removed from the analysis, leaving 10 pigs in the co-infected group. On DPI 
4, five random co-inoculated pigs and all six of the singly inoculated pigs were euthanized, and 
then tonsils and ileocecal lymph nodes were collected. The remaining five pigs were euthanized 
on DPI 10 with collection of tonsils and ileocecal lymph nodes. 
The competition index (CI) was calculated using the following formula: (X – Y)/(X + Y), 
in which X is the number of Salmonella 4,[5],12:i:- colonies and Y is the number of Salmonella 
Typhimurium colonies42. A CI value that is positive indicates that Salmonella 4,[5],12:i:- is more 
fit while a value that is negative indicates that Salmonella Typhimurium is more fit. A CI value 
closer to 1 or -1 indicates dominance of Salmonella 4,[5],12:i:- or Salmonella Typhimurium, 
respectively.  
 
Statistical analysis 
No statistical analysis was completed for animal study #1 as the goals of the study could 
be accomplished without statistical analysis. For the data sets from animal studies #2 and #3, the 
population homogeneity was assessed using the Shapiro-Wilk test and the population variance 
was assessed using the Brown-Forsythe test. Based on the results from these two tests, either 
parametric or non-parametric tests were chosen. For brevity, the same statistical test was used for 
each dependent variable when necessary (i.e. temperature, quantitative culture). For quantitative 
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culture of feces from animal study #2, one-way ANOVA followed by Dunnett’s test was used to 
compare the mean amount of Salmonella on a log10 basis on DPI 0 to the mean amount of 
Salmonella on all other days, within each serovar. For the rectal temperatures from animal study 
#2, the Kruskal-Wallis test with Dunn’s post test was utilized to compare the mean temperature 
on each DPI to the day of inoculation (DPI 0) within each serovar. Rectal temperatures, fecal 
scores, and histologic lesion scores were also compared between serovar groups at each DPI 
using the GLIMMIX procedure of the SAS System to complete the Tukey-Kramer test. For 
quantitative fecal culture from animal study #3, Poisson distribution was used to compare S. 
Typhimurium to S. 4,[5],12:i:- at each DPI. For all tests, a P-value less than 0.05 was deemed 
significant.  
 
Results 
Animal study #1 
Results of the preliminary animal study comparing three separate isolates of Salmonella 
4,[5],12:i:- demonstrated that clinical disease, as indicated by a rectal temperatures outside of the 
normal range (101.5-103.5˚F) (Figure 2) and/or diarrhea (fecal score greater than or equal to 2.5) 
(Figure 3), was induced by all isolates, although isolates A and B caused an increase in rectal 
temperature and in fecal score while isolate C caused an increase in the fecal score only. Fecal 
scores and temperatures from the three isolates, averaged among each group, reached their peak 
at DPI 3 and 2, respectively. There was detectable shedding of Salmonella in the feces with 
direct culture throughout the entire seven-day study in piglets inoculated with isolates A and B. 
For the group inoculated with isolate C, mild clinical disease was noted with Salmonella 
shedding only detectable through DPI 4 in pre-enrichment feces. However, Salmonella was 
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detectable in enriched fecal samples from all pigs at all time points for all groups inoculated with 
each of the three isolates (Table 2).  
Ileocecal lymph nodes, tonsils, spleen, and liver were collected at the time of necropsy on 
DPI 7, with culture results listed in Table 2. The spleen and liver proved to be a poor sample type 
for the detection of Salmonella 4,[5],12:i:- infections as only one out of nine and two out of nine 
pigs, respectively, were positive for Salmonella by quantitative and/or enrichment culture. 
Ileocecal lymph nodes and tonsils proved to be a better sample for detection of Salmonella 
4,[5],12:i:- as nine out of nine and seven out of nine pigs, respectively, were positive for 
Salmonella by direct and/or enrichment culture. Although Salmonella 4,[5],12:i:- was detectable 
in the feces and tissues of the majority of pigs, only one out of nine pigs had gross lesions 
suggestive of salmonellosis, which consisted of fibrinous colitis; this pig was inoculated with 
isolate B. Histopathologic evaluation of intestinal tissues on the basis of neutrophil infiltration, 
crypt elongation, and ulceration revealed that the cecum and spiral colon were the primary target 
of Salmonella 4,[5],12:i:-, regardless of the specific isolate involved in infection, with minimal to 
no lesions in the small intestine and rectum (Figure 4). From this combination of data, isolate B 
of S. 4,[5],12:i:- was selected for the full scale animal study described below. 
 
Animal study #2 
Clinical disease  
 Based on rectal temperature and fecal scoring, overall, Salmonella Typhimurium and 
Salmonella 4,[5],12:i:- both appeared to cause a similar short-lived clinical disease that was more 
severe than that caused by S. Derby infection. The rectal temperature results are shown in 
Figures 5A-5D. Those infected with S. 4,[5],12:i:- had a peak mean temperature on DPI 2 at 
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102.7˚F (± 0.3), but this was not significantly different from DPI 0 until DPI 5, 6, 7, 10, and 17 
(Figure 5A). The mean temperature (± SE) of pigs infected with S. Typhimurium peaked on DPI 
2 at 103.2˚F (± 0.3), with a statistically significant increase relative to DPI 0 on DPI 1, 2, and 4 
(Figure 5B). Salmonella Derby-inoculated pigs developed the highest mean temperature on DPI 
1 at 103.1˚F (± 0.1), with a significant difference from DPI 0 on DPI 1 only (Figure 5C). The 
control pigs had a significantly elevated temperature compared to their DPI 0 mean on DPI 5, 6, 
and 10 (Figure 5D). Interestingly, there were a number of animals with temperatures that were 
both significantly higher and lower than normal in the S. Typhimurium and S. 4,[5],12:i:- groups, 
but not the control or S. Derby groups. Thus, calculation of the average temperature in each 
group may not be the best measure of clinical disease manifestation in these groups as severely 
ill animals can also exhibit lower than normal body temperatures. For example, on DPI 1, 2, 3, 
and 4, 25%, 45%, 27%, and 87%, respectively, of S. 4,[5],12:i:- infected pigs had rectal 
temperatures outside the normal range of 101.5-103.5˚F. This is in contrast to 0%, 18%, 0%, and 
22% for control pigs over the same time period. 
The fecal score results are shown in Figure 6. The mean fecal score (± SE) of S. 
Typhimurium-infected pigs peaked on DPI 2 at 3.7 (± 0.3) and S. 4,[5],12:i:- -infected pigs 
peaked on DPI 2 at 3.5 (± 0.3). The S. Derby infected pigs reached a mean fecal score on DPI 4 
of 2.8 (± 0.2) with all other mean fecal scores being at or below 2.4, therefore indicating that S. 
Derby did not successfully induce diarrhea in the pigs with the exception of DPI 4. The sham-
inoculated control pigs reached a peak fecal score on DPI 28 at 3.5 (± 0.2), but also had elevated 
mean fecal scores on DPI 10 at 3.3 (± 0.2) and DPI 3 at 2.9 (± 0.4). Salmonella 4,[5],12:i:- had a 
significantly increased mean fecal score relative to S. Derby and S. Typhimurium pigs on DPI 0. 
The mean fecal score of S. 4,[5],12:i:- pigs was significantly increased relative to S. 
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Typhimurium on DPI 1 and S. Derby and the controls on DPI 2. The mean fecal score of S. 
Typhimurium pigs was also significantly increased relative to S. Derby and the controls on DPI 
2. Salmonella 4,[5],12:i:- pigs had a significantly higher mean fecal score relative to the controls 
on DPI 4.  
 
Bacterial culture  
 All pre-inoculation fecal samples were negative for Salmonella culture. Throughout the 
duration of the study, all samples collected from the control pigs were confirmed negative for 
Salmonella by enrichment culture. Fecal culture results are listed in Table 3 and depicted in 
Figure 7. The mean amount of Salmonella, on log10 basis of colony forming units (CFU) per 0.5 
grams of feces, peaked at 3.0 (± 0.1) on DPI 4 in S. Typhimurium infected pigs. Pigs infected 
with S. 4,[5],12:i:- reached a peak level of Salmonella in feces on DPI 2 at 3.4 (± 0.2) with those 
with S. Derby also reached a peak level on DPI 2 at 2.9 (± 0.1). All serovar groups had a 
significantly increased amount of Salmonella in the feces on DPI 2, 4, and 7 relative to DPI 0, 
and S. Typhimurium also had a significantly increased amount in the feces on DPI 14. Enriched 
feces remained positive for Salmonella in the S. Typhimurium group in 20% of pigs (2 of 10) on 
DPI 28, while S. 4,[5],12:i:- only remained positive until DPI 21, at which time 30% of fecal 
samples (3 of 10) were positive.  
Samples were also collected for culture from pigs at necropsy on DPI 2, 4, and 28. 
Culture results of samples collected at necropsy are listed in Table 4. On DPI 2 and 4, all 
Salmonella-infected pigs, with the exception of one S. Derby-infected pig on DPI 4, had 
detectable levels of Salmonella in their colon contents. The liver and spleen of Salmonella-
infected pigs had variable results based infecting serovar and timing after inoculation, ranging 
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from 60% of S. Typhimurium pigs positive in the liver on DPI 2 while S. Derby inoculated pigs 
were negative for Salmonella in the spleen and liver at all necropsy time points. The ileocecal 
lymph nodes were positive on DPI 2 and 4 from all Salmonella-infected pigs. However, the 
lymph nodes were only positive in 50% (5 of 10) of S. 4,[5],12:i:- pigs, 67% (6 of 9) of S. Derby 
pigs, and 40% (4 of 10) of S. Typhimurium pigs on DPI 28. Tonsils were positive from all 
Salmonella-infected pigs on DPI 2 and 4, except for three S. Derby pigs on DPI 4 and one S. 
Typhimurium pig on DPI 2. On DPI 28, tonsils were positive for Salmonella from 90% (9 of 10) 
of S. 4,[5],12:i:- pigs, 67% (6 of 9) of S. Derby pigs, and 40% (4 of 10) of S. Typhimurium pigs.  
 
Gross lesions  
 Gross lesions suggestive of salmonellosis were absent in all control pigs and S. Derby 
infected pigs necropsied on DPI 2 but were present in two out of five S. Typhimurium pigs and 
two out of five S. 4,[5],12:i:- pigs. At DPI 4, similar results were found, with two out of five S. 
4,[5],12:i:- pigs and four out of five S. Typhimurium pigs possessing gross lesions suggestive of 
salmonellosis while none of the control or S. Derby pigs had gross lesions. Representative gross 
lesions from S. 4,[5],12:i:- and S. Typhimurium pigs on DPI 4 are shown in Figure 8A and 8B, 
respectively. However, by DPI 28, only one S. Typhimurium pig and one S. 4,[5],12:i:- pig had 
gross lesions suggestive of salmonellosis.  
 
Histopathology  
In alignment with the histopathologic results from study #1 of three S. 4,[5],12:i:- 
isolates, ulceration, neutrophil infiltration, and crypt elongation were primarily limited to the 
cecum and spiral colon for all serovars (Figure 9). On DPI 2 (Figure 9A), there were statistically 
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significant differences in histologic lesion scores in the ileum, cecum, and spiral colon. In the 
ileum, S. 4,[5],12:i:- had significantly more severe lesions than control and S. Derby pigs but not 
more severe than S. Typhimurium. In the cecum and mid spiral colon, S. Typhimurium and S. 
4,[5],12:i:- had significantly more severe lesions than control and S. Derby but not more severe 
than one another. In the apex of the spiral colon, S. Typhimurium had significantly more severe 
lesions than S. 4,[5],12:i:-, control, and S. Derby, but S. 4,[5],12:i:- lesions were not significantly 
different from those of S. Derby or control. On DPI 4 (Figure 9B), there were statistically 
significant differences in the histologic lesion scores in the cecum and mid spiral colon only. In 
the cecum, S. 4,[5],12:i:- had significantly more severe lesions than S. Typhimurium, S. Derby, 
and controls, but S. Typhimurium did not possess significantly more severe lesions than S. Derby 
or controls. In the mid spiral colon, S. Typhimurium and S. 4,[5],12:i:- had significantly more 
severe lesions than control and S. Derby but not more severe than one another. On DPI 28 
(Figure 9C), there were no statistically significant differences in the histologic scores between 
the treatment groups in any of the intestinal sections evaluated. Overall, histopathologic lesions 
suggestive of clinical salmonellosis were present consistently in the S. Typhimurium and S. 
4,[5],12:i:- groups on DPI 2 and 4 but not the S. Derby or control groups. Salmonella 4,[5],12:i:- 
infection resulted in a similar severity of diarrhea, disturbance in rectal temperature, colonization 
of tissues, and gross and histologic lesions as with Salmonella Typhimurium infection. 
Balantidium coli, a secondary pathogen, was noted upon histologic examination in a 
portion of pigs from all groups euthanized on DPI 2 (5/5 4,[5],12:i:- pigs, 1/5 Typhimurium pigs, 
1/5 Derby pigs, and 0/2 control pigs), 4 (5/5 4,[5],12:i:- pigs, 3/5 Typhimurium pigs, 2/5 Derby 
pigs, and 0/3 control pigs), and 28 (1/10 4,[5],12:i:- pigs, 2/10 Typhimurium pigs, 0/9 Derby 
pigs, and 0/3 control pigs), respectively. Cryptosporidium was also detected on DPI 2 (in 2/5 
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4,[5],12:i:- pigs, 1/5 Typhimurium pig, 2/5 Derby pigs, and 1/2 control pigs) and on DPI 4 (in 
3/5 4,[5],12:i:- pigs, 1/5 Typhimurium pig, 3/5 Derby pigs, and 2/3 control pigs). No 
Cryptosporidium was detected on DPI 28. The presence of Cryptosporidium did not appear to 
cause a severe increase in the fecal scores, rectal temperatures, or histopathologic scores in any 
of the treatment groups as the majority of these measurements were either equivalent between 
pigs that were positive and negative for Cryptosporidium or higher in those that were negative 
for Cryptosporidium. No other lesions suggestive of clinical disease caused by other pathogens 
of swine were detected during the histopathologic examination. 
 
Animal study #3 
 To ensure that both the S. Typhimurium and S. 4,[5],12:i:- isolates were able to cause 
disease when infecting a pig individually, three pigs were inoculated with only S. Typhimurium 
and three with only S. 4,[5],12:i:-. In S. 4,[5],12:i:- infected pigs, the mean temperature peaked 
on DPI 2 at 102.5˚F. Salmonella Typhimurium infected pigs had a peak mean temperature of 
102.4˚F on DPI 4. The peak mean fecal scores of each group were 3.7 on DPI 3 in S. 4,[5],12:i:- 
infected pigs and 3 on DPI 2 and DPI 4 in S. Typhimurium infected pigs. These results together 
indicate that both isolates were able to individually cause mild clinical disease in pigs. In pigs 
that received both S. Typhimurium and S. 4,[5],12:i:-, the mean fecal score peaked on DPI 1 at 
4.1, but remained above 3.5 on DPI 2, 3, and 4. The mean temperature of co-infected pigs 
peaked at 103.3˚F on DPI 2. There was a notable increase in the severity and duration of clinical 
disease in pigs infected simultaneously with S. Typhimurium and S. 4,[5],12:i:- compared to pigs 
infected with only one serovar of Salmonella. 
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 In the 10 pigs that completed the co-inoculation study, there was a higher mean amount 
of S. 4,[5],12:i:- detected via culture compared to S. Typhimurium at DPI 1, 2, 3, 4, 5, and 10, 
and the difference was statistically significant on DPI 1, 2, 3, 4, and 10 (Figure 10). The largest 
difference in amounts of S. 4,[5],12:i:- and S. Typhimurium occurred on DPI 2. On DPI 7, the 
only time point in which the average amount of S. Typhimurium exceeded the amount of S. 
4,[5],12:i:- in feces, the difference was not statistically significant. In addition, when compared 
to singly infected pigs, co-infected pigs shed Salmonella at higher levels on average. Of the three 
pigs infected with S. 4,[5],12:i:- and four samples collected from each pig on DPI 1-4, only three 
out of 12 samples had detectable levels of Salmonella present in their feces. Similar results were 
found with the S. Typhimurium pigs, with only three out of 12 samples possessing detectable 
levels of Salmonella.  
All three pigs infected with S. Typhimurium were positive for Salmonella in their tonsils 
and ileocecal lymph nodes on DPI 4. Of the three pigs infected with S. 4,[5],12:i:-, only one had 
Salmonella present in the tonsils on DPI 4, and two had Salmonella in the ileocecal lymph nodes. 
This is in contrast to those pigs that were infected simultaneously with both S. Typhimurium and 
S. 4,[5],12:i:-, in which seven pigs had tonsils culture positive for S. 4,[5],12:i:- and six pigs 
positive for S. Typhimurium (Figure 11). Of those pigs positive for Salmonella in their tonsils, 
five had higher levels of S. 4,[5],12:i:-, two had higher levels of S. Typhimurium, and 3 had 
equivalent levels of the two serovars. As for the ileocecal lymph nodes, eight pigs were positive 
for S. 4,[5],12:i:- and six were positive for S. Typhimurium. Similar to the tonsils, five had 
higher levels of S. 4,[5],12:i:-, one had higher levels of S. Typhimurium, and four had equivalent 
levels of the two serovars. The competition index (CI) was calculated for each set of samples 
collected. In the feces on all days except for DPI 7, the competition index was greater than zero, 
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indicating that S. 4,[5],12:i:- has a higher level of fitness compared to S. Typhimurium (Figure 
12A). Upon necropsy on DPI 4 (Figure 12B), the CI was greater than zero (0.32 and 0.39 in the 
tonsils and ileocecal lymph nodes, respectively). Upon necropsy on DPI 10 (Figure 12B), the CI 
was also greater than zero (0.52 and 0.20 in the tonsils and lymph nodes, respectively). These 
results indicate that S. 4,[5],12:i:- also demonstrated a higher level of fitness in colonization of 
tonsils and ileocecal lymph nodes when compared to S. Typhimurium. 
 
Discussion 
The work completed in these studies clearly demonstrates that Salmonella serovar 
4,[5],12:i:- possesses a similar ability as Salmonella Typhimurium to cause significant clinical 
disease in swine. In addition, this serovar, along with Typhimurium and Derby, can be carried in 
the tonsils and lymph nodes and shed in the feces of infected animals for weeks following 
exposure and illness. Potential sequelae to this carriage includes likely contamination of the 
environment with subsequent infection of pen mates and contamination of carcasses and meat at 
harvest leading to food safety concerns. Overall, all three animal studies provided insight into the 
pathogenesis of disease caused by S. 4,[5],12:i:- in swine. Animal study #1 allowed us to 
compare three separate isolates of S. 4,[5],12:i:-, all of which had retained their ability to cause 
disease through the culture process as indicated by the observed fever and/or diarrhea. Fecal 
shedding for all isolates continued for the duration of the study from DPI 1-7.  
Animal study #2 enabled evaluation of the pathogenicity, fecal shedding, and 
colonization of swine by S. Typhimurium, S. 4,[5],12:i:-, and S. Derby. The mean rectal 
temperature of pigs infected with all three Salmonella serovars peaked at DPI 1-2 The mean 
fecal score reached its peak at DPI 2 for S. Typhimurium and S. 4,[5],12:i:-, with S. Derby 
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reaching a lower peak at a later time than the other two serovars. The rectal temperatures and 
fecal scores indicated that S. 4,[5],12:i:- has a similar disease-causing ability to S. Typhimurium 
and induces a more severe disease than that caused by S. Derby. Fecal shedding continued 
through DPI 28 for S. Typhimurium and DPI 21 for S. 4,[5],12:i:- and S. Derby. The colonization 
of tonsils and ileocecal lymph nodes appeared to be similar across DPI 2, 4, and 28 in all three 
serovar groups. Gross lesions suggestive of Salmonellosis were concentrated to DPI 2 and 4 and 
were limited to those pigs infected with S. Typhimurium or S. 4,[5],12:i:-. Histologic lesions 
occurred primarily in the cecum and spiral colon, with significantly higher scores in the pigs 
infected with S. Typhimurium and S. 4,[5],12:i:-.  
 Animal study #3 revealed that co-infection with S. 4,[5],12:i:- and S. Typhimurium 
simultaneously may cause a more severe clinical disease compared to infection with only one 
serovar, as indicated by the more severe fever and diarrhea in co-infected pigs relative to singly-
infected pigs. It is unclear if the increased disease severity in co-infected pigs was the result of a 
synergistic effect of the two serovars or the higher inoculum dose in co-infected pigs. The S. 
4,[5],12:i:- isolate demonstrated a competitive advantage of S. Typhimurium in vivo, which is 
evidenced by the significantly higher mean levels of S. 4,[5],12:i:- relative to S. Typhimurium on 
DPI 1, 2, 3, 4, and 10. 
Many studies have demonstrated that S. 4,[5],12:i:- is a monophasic variant of S. 
Typhimurium based on pulsed-field gel electrophoresis (PFGE)11,43,44, multiple-locus variable 
analysis (MLVA)8,45, polymerase chain reaction (PCR)10,14,46, phage typing11,44,47,48, and whole-
genome sequencing49,50. However, the characterization of S. 4,[5],12:i:- as a pathogen of swine 
has not been as readily documented. To our knowledge, only two studies have been published on 
experimental infections of swine with S. 4,[5],12:i:-, leaving a large gap in our understanding of 
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this emerging serovar. One of the recently published studies was a small-scale study in 
experimentally infected swine, which revealed that S. 4,[5],12:i:- has maintained a similar 
disease-causing ability to that typically associated with S. Typhimurium20. Specifically, at DPI 2, 
the infected pigs developed a fever and diarrhea, and they shed Salmonella 4,[5],12:i:- in their 
feces throughout the seven days following inoculation20. Overall, the authors of this study 
concluded that both S. Typhimurium and its monophasic variant, S. 4,[5],12:i:-, can cause 
gastrointestinal disturbances, further substantiating the claim that expression of only one flagellar 
phase does not alter the pathogenicity20,35. The results of this small-scale study with respect to 
the clinical disease established by S. 4,[5],12:i:- was in alignment with our work as we 
determined that diarrhea and fever occur on DPI 2 following infection with S. 4,[5],12:i:- and 
that the disease and lesions induced by S. 4,[5],12:i:- closely resemble that induced by S. 
Typhimurium. However, that study utilized fecal moisture content to determine if the pigs had 
developed diarrhea20. Fecal moisture content analysis is a much more objective way to evaluate 
the level of diarrhea in swine compared to fecal scoring, even though fecal scoring is a more 
common method in studies of this type41,51. Due to the size and scope of our study, we utilized 
fecal scoring to facilitate evaluation of a larger sample size.  
The other study that was recently completed was similar to our comparison of Salmonella 
serovars 4,[5],12:i:-, Typhimurium, and Derby19. In contrast to our findings, this study found that 
all S. 4,[5],12:i:-, S. Derby, and S. Typhimurium infected pigs, with the exception of one S. 
Derby pig on DPI 21, one S. Typhimurium pig on DPI 14, and one S. Typhimurium pig on DPI 
45, were shedding Salmonella throughout the study at all time points from DPI 1-4919. This is 
contrary to the findings of our study and other studies that have reported that Salmonella 
shedding varies on an individual basis, varies with the infecting serovar, and is not 
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continuous2,28-30. The deviation in this study from what has been reported previously from other 
studies and our findings is likely due to the larger amount of feces collected for culture, as this 
study used 30 grams of feces and an increased fecal sample mass has been correlated to 
increased sensitivity52. This study also reported that S. 4,[5],12:i:- infection of swine resulted in 
fever and diarrhea on DPI 21 while diarrhea observed in pigs infected with S. Typhimurium 
occurred on DPI 7 and 10 and with S. Derby on DPI 1419. This is much different from that 
observed in other studies of experimental infections with S. Typhimurium and S. 4,[5],12:i:- in 
swine, which generally report fever and diarrhea on DPI 2-420,53,54, as well as our study which 
also indicated disease occurs much sooner after infection.  
Salmonella Typhimurium is well-recognized as an enteric pathogen of swine. Many 
studies have been completed to determine the course of disease typical of the pathogen. It caused 
significantly increased rectal temperatures and fecal scores in three to four week old pigs at DPI 
2-3 while also colonizing the liver, spleen, tonsils, and ileocecal junction53. Another study 
echoed similar findings in four-week old experimentally infected pigs, with 100% of pigs 
shedding Salmonella in their feces through DPI 28, 20% developing a fever (>103˚F), and 55% 
exhibiting diarrhea55. Both of these studies came to similar conclusions to the conclusions that 
were reached following our animal study #2: S. Typhimurium causes fever, diarrhea, and fecal 
shedding of the organism following infection. Salmonella Derby has been less thoroughly 
evaluated in vivo in swine, likely due to its lesser-pathogenicity. However, one study found that 
it is shed in the feces of some pigs through DPI 56 and potentially even longer, indicating an 
ability to persist within the host30. The results from our studies showed S. Derby is shed for a 
shorter duration in the feces, specifically through DPI 21, compared to the study that reported 
fecal shedding of S. Derby occurs for 8 weeks post infection. Given the presence of Salmonella 
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in the tissues collected on DPI 28 from all three groups, however, including S. Derby, it is clear 
that Salmonella is able to persist within infected pigs through DPI 28. The absence of Salmonella 
in feces was likely the result of low diagnostic sensitivity in our study and/or a low quantity of 
Salmonella being shed rather than an absence of infection. 
A subset of pigs in animal study #2 developed a fever while another subset developed 
hypothermia. When comparing the mean rectal temperatures of the pigs in each treatment group, 
it was noted that S. 4,[5],12:i:- did not appear to successfully induce a fever. However, 
evaluation of the rectal temperatures of the pigs by the percentage within, above, or below the 
normal temperature range (101.5-103˚F) revealed that S. 4,[5],12:i:- caused a fever in some and 
hypothermia in others. Specifically, in the first four days following infection, S. 4,[5],12:i:- had 
25-90% of pigs with rectal temperatures outside of the normal range, which was comparable to 
S. Derby pigs with 11-50% outside of the normal range and S. Typhimurium pigs with 20-35% 
outside of the normal range. This is in contrast to the control pigs in which no more than 22% of 
pigs had rectal temperatures outside of the normal range during the same timeframe. Fever is 
widely accepted as a response to infection, as it creates a more hostile environment for the 
bacteria within the host to improve host resistance to spread of the infection. However, 
hypothermia represents another potential response to infection. Hypothermia is a mechanism in 
place thought to downregulate pro-inflammatory cytokine release to reduce excessive tissue 
damage and is generally associated with severe systemic infection56,57. Oddly, the control pigs as 
well as the S. 4,[5],12:i:- also exhibited as a group decreased body temperatures between DPI 5-
7; as the whole group experienced this change, it is likely that room temperature fluctuations 
contributed to this changes in these groups. All four experimental groups were housed in 
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separate rooms throughout the study which may explain why this was not seen in the other two 
groups.  
When co-inoculated at the same levels, S. 4,[5],12:i:- was consistently detected in the 
feces of a higher percentage of pigs and at higher levels than S. Typhimurium in our study. 
Additionally, the competition index showed that S. 4,[5],12:i:- has a greater level of fitness in the 
host than S. Typhimurium. This finding may partly explain why S. 4,[5],12:i:- has been 
increasingly identified in swine diagnostic samples over the past several years. Additional data 
suggests that co-infection may promote enhanced clinical disease in swine. Although no studies 
have been published on the clinical disease resulting from simultaneous infections with more 
than one serovar of Salmonella, there have been reports of simultaneous infections of Salmonella 
and other viral or bacterial pathogens of swine having additive effects58,59. 
Identification of co-infections is likely rare in practice as only a single colony of 
Salmonella is typically selected from the culture plate for final identification and 
characterization60,61, leaving the possibility for co-infections to be occurring frequently yet rarely 
detected. Future research is warranted to better understand the impact that co-infections might 
play in clinical disease in the field. Our results showed a potential synergism between S. 
4,[5],12:i:- and S. Typhimurium in swine, but a larger sample size and equivalent inoculum 
concentrations between co-infected and singly-infected groups would be necessary to confirm 
this.  
Our studies were not completed without limitations. All samples collected for culture 
were frozen at -80˚C from the time of collection to the time of processing up to two months later. 
The freezing and thawing process may have reduced the viability of some of the Salmonella 
initially present in the samples62. Ideally, all samples would have been processed within several 
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hours of collection without any freezing; unfortunately, the large volume of samples collected at 
any given time point made this option less feasible. An alternative to culture is PCR testing. 
Many PCR tests have been validated for the detection and identification of Salmonella63-65, 
which would have also been able to quantify the Salmonella present in the samples, however, 
this method was not cost-effective for the large number of samples collected during this study. 
An additional culture-related limitation was the relatively small amount of feces used for culture. 
The diarrhea induced by the Salmonella infection created challenges regarding collection of large 
amounts of feces from the rectum of each pig, therefore, a lesser amount of starting material was 
used that might have been ideal to increase the sensitivity of the test.  
In an effort to increase the odds of detecting acute gross and histologic lesions induced by 
Salmonella infections, Salmonella-infected pigs in animal study #2 were selected for euthanasia 
on DPI 2 and 4 based on severity of clinical disease. That is, pigs with the highest combined 
fecal score and rectal temperature in each pen were selected for euthanasia. There is known to be 
significant individual-level variation in the effects of Salmonella infections in pigs, with some 
pigs even failing to develop clinical signs, gross lesions, and/or histologic lesions suggestive of 
infection. If there is a correlation between the severity of clinical disease and persistence of 
infection or colonization of tissues, these measurements could be biased. The method of 
selection utilized on DPI 2 and 4 likely also increased the mean gross and histologic lesion 
scores on these days while potentially decreasing the mean scores on DPI 28. It also may have 
decreased the mortality rate following Salmonella infections. However, it enabled 
characterization of the location and types of lesions induced by Salmonella. 
 During the histopathologic evaluation of tissues from animal study #2, Cryptosporidium 
and Balantidium coli were noticed from a portion of the pigs in all serovar groups and the control 
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group at all euthanasia time points. The presence of Cryptosporidium did not appear to cause a 
severe increase in the fecal scores, rectal temperatures, or histopathologic scores in any of the 
treatment groups. This is evidenced by the fact that, in a comparison of the mean fecal scores, 
rectal temperatures, and histopathologic scores, the majority of measurements were either 
equivalent between pigs that were positive and negative for Cryptosporidium or higher in those 
that were negative for Cryptosporidium. Cryptosporidium can cause a mild and self-limiting 
diarrhea in pigs, although it generally causes an asymptomatic infection66, so its effect on the 
pigs in this study remains unknown. Cryptosporidium was not one of the pathogens that the pigs 
were screened for prior to arrival, so it is unclear when the infection was obtained. While it 
would be most ideal to screen the pigs for all possible pathogens including Cryptosporidium 
prior to enrollment in the study, it would be an inefficient use of resources; therefore, the 
pathogens of the highest concern were selected for screening. Balantidium coli was also noted in 
the intestinal sections of some pigs. However, this is not generally considered to be a primary 
pathogen67 and was likely not independently the cause of diarrhea in the pigs. The fecal scores 
and rectal temperatures of the control group were mildly increased in the last 1-2 weeks of 
animal study #2, which could have been due to infection by a non-Salmonella pathogen. Further 
testing of samples for other pathogens was not pursued, however, given the lack of 
histopathologic evidence of the presence of other pathogens of concern.  
 A potential confounder of animal study #3 was the difference in the inoculum dose 
provided to singly-infected pigs and co-infected pigs. All pigs were infected with the same dose 
of each serotype, which was 1.38 x 108 CFU/mL for those receiving S. Typhimurium and 1.73 x 
108 CFU/mL for those receiving S. 4,[5],12:i:-. The co-infected pigs received two doses of 
inoculum though as they were infected with a full dose of S. 4,[5],12:i:- and a full dose of S. 
100 
 
 
Typhimurium, resulting in twice as much Salmonella in the inoculum as that received by the 
singly-infected pigs. However, this is a comparatively small difference, with singly-infected pigs 
receiving just 0.35 log10 CFU/g less Salmonella at most than co-infected pigs. If this study were 
to be repeated, administration of the same total dose of Salmonella in the inoculum for singly 
and co-infected pigs would aid in differentiation of the effect of the dose from the effect of the 
co-infection.  
 In conclusion, our results clearly indicate that S. 4,[5],12:i:- induces clinical disease 
comparable to that of S. Typhimurium with similar corresponding gross and histopathologic 
lesions. The cause of the emergence of the monophasic serovar may be due in part to the 
competitive advantage S. 4,[5],12:i:- may possess in vivo, as evidenced by the higher mean levels 
of S. 4,[5],12:i:- relative to S. Typhimurium in the majority of pigs infected with the two serovars 
simultaneously. Future research should focus on assessing the frequency and potential 
synergistic effects of concurrent S. 4,[5],12:i:- and S. Typhimurium infections in swine. 
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Tables 
Table 1. Summary of histopathologic measurements obtained from each of the evaluated tissue 
sections during all three animal studies. 
Histopathologic Evaluation 
Tissue Location Obtained Measurements 
Proximal jejunum 
Mid jejunum 
Distal jejunum 
Ileum 
Neutrophil count* 
Ulceration score† 
Cecum 
Apex of spiral colon 
Mid spiral colon 
Rectum 
Neutrophil count* 
Crypt depth‡ 
Ulceration score† 
Ileocecal lymph node 
Spleen 
Liver 
Neutrophil presence§ 
FOV = field of view; TNTC = too numerous to count 
*Average of 5 neutrophil counts; at 400X FOV, >100 neutrophils in one FOV was considered TNTC and listed as 
100 
†Number of crypts over which most severe ulceration foci extended, ranging from 0-5 (5 = ulcer spanning five or 
more crypts) 
‡Average of three crypt depths measured at 10X FOV 
§Presence or absence of neutrophils (in any amount) in 5-400X FOV, ranging from 1-5 (1 = no neutrophils observed 
in 5 FOV, 5 = neutrophils observed in all 5 FOV) 
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Table 2. Culture results of three separate isolates of Salmonella 4,[5],12:i:- from animal study 
#1. 
 Culture positives† 
Inoculum 
Fecal Samples (DPI) Necropsy Samples* 
2 4 7 Liver Spleen IC LN Tonsils 
S. 4,[5],12:i:- (A) 
100% 100% 100% 33% 0% 100% 100% 
3/3 3/3 3/3 1/3 0/3 3/3 3/3 
S. 4,[5],12:i:- (B) 
100% 100% 100% 0% 0% 100% 33% 
3/3 3/3 3/3 0/3 0/3 3/3 1/3 
S. 4,[5],12:i:- (C) 
100% 100% 100% 33% 33% 100% 100% 
3/3 3/3 3/3 1/3 1/3 3/3 3/3 
DPI = days post inoculation; IC LN = ileocecal lymph node 
*Necropsy samples were collected on DPI 7 
†Positives were positive for Salmonella from quantitative culture and/or enrichment culture  
 
Table 3. Comparison of Salmonella culture results in feces collected from pigs inoculated with 
Salmonella serovars 4,[5],12:i:-, Typhimurium and Derby in animal study #2. 
 
DPI = days post inoculation  
*Positives were positive for Salmonella from quantitative and/or enrichment culture  
 
  
 Fecal culture positives* 
Inoculum 
DPI 
2 4 7 14 21 28 
S. 4,[5],12:i:- 
100% 73% 90% 40% 30% 0% 
20/20 11/15 9/10 4/10 3/10 0/10 
S. Typhimurium 
95% 93% 60% 40% 20% 20% 
19/20 14/15 6/10 4/10 2/10 2/10 
S. Derby 
95% 79% 67% 11% 11% 0% 
18/19 11/14 6/9 1/9 1/9 0/9 
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Table 4. Comparison of Salmonella culture results from samples collected during necropsy from 
pigs inoculated with Salmonella serovars 4,[5],12:i:-, Typhimurium and Derby in animal study 
#2 
 Culture Positives* 
Inoculum 
Necropsy 
DPI 
Location 
Colon Liver Spleen IC LN Tonsils 
S. 4,[5],12:i:- 
2 
100% 40% 20% 100% 100% 
5/5 2/5 1/5 5/5 5/5 
4 
100% 40% 20% 100% 100% 
5/5 2/5 1/5 5/5 5/5 
28 
10% 0% 0% 50% 90% 
1/10 0/10 0/10 5/10 9/10 
S. Derby 
2 
100% 0% 0% 100% 100% 
5/5 0/5 0/5 5/5 5/5 
4 
80% 0% 0% 100% 40% 
4/5 0/5 0/5 5/5 2/5 
28 
0% 0% 0% 67% 67% 
0/9 0/9 0/9 6/9 6/9 
S. Typhimurium 
2 
100% 60% 20% 100% 80% 
5/5 3/5 1/5 5/5 4/5 
4 
100% 20% 0% 100% 100% 
5/5 1/5 0/5 5/5 5/5 
28 
30% 0% 0% 40% 40% 
3/10 0/10 0/10 4/10 4/10 
DPI = days post inoculation; IC LN = ileocecal lymph nodes 
*Positives were positive for Salmonella from quantitative and/or enrichment culture  
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Figures 
Fecal Score Description Image 
1 Firm and dry 
 
2 Firm and moist 
 
3 
“Cow-pie” 
appearance; 
increasingly moist 
with no clumping on 
digital rectal exam 
 
4 
“Pancake” 
appearance; 
increasingly moist, 
flattens out on floor  
5 
Consistency resembles 
water 
 
 
Figure 1. Depiction and explanation of fecal scoring system utilized for all three animal 
studies to determine the level of diarrhea. 
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Figure 2. Mean rectal temperatures from animal study #1 following inoculation on DPI 0 
with three separate isolates of S. 4,[5],12:i:- (A, B, and C). The mean and standard error are 
represented by the bars.  
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Figure 3. Mean fecal scores from animal study #1 following inoculation on DPI 0 with three 
separate isolates of S. 4,[5],12:i:- (A, B, and C). The fecal scoring system ranged from 1-5, 
with 1-2 being considered normal and 5 being considered severe diarrhea. The mean and 
standard error are represented by the bars.  
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Figure 4. Histologic scores from samples collected at necropsy on day seven following 
inoculation with three separate isolates of S. 4,[5],12:i:- (A, B, and C) in animal study #1. 
These scores depict the average histologic lesions, as determined by the ulceration, neutrophil 
infiltration, and crypt elongation and abscessation, and submucosal inflammation, at the time of 
necropsy on DPI 7. The mean of each isolate-tissue location combination is represented by the 
bar with the standard error represented by the line.  
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Figure 5A.          Figure 5B.  
Figure 5. Comparison of rectal temperatures of pigs inoculated with Salmonella serovars (5A) 4,[5],12:i:-, (5B) Typhimurium, 
and (5C) Derby and (5D) non-inoculated control pigs in animal study #2. Asterisks represent significant differences from the 
mean temperature on DPI 0 (p<0.05). Each datum point represents the temperature in individual animal; short horizontal bar 
represents mean temperature within a group; long horizontal bars located at 101.5˚F and 103.5˚F, between which is the normal 
temperature range for swine.  
 
1
1
3
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Figure 5C. (continued)        Figure 5D. (continued)
1
1
4
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Figure 6. Comparison of fecal scores of pigs inoculated with Salmonella serovars  
4,[5],12:i:-, Typhimurium, and Derby and non-inoculated control pigs in animal study #2. 
Symbols represent the mean, with vertical bars representing standard error of the mean. Fecal 
scores of 1-2 are normal, 3 is mild diarrhea, 4 is moderate diarrhea, and 5 is severe diarrhea. 
 
116 
 
 
 
Figure 7. Comparison of quantitative culture results for Salmonella in feces collected from 
pigs inoculated with Salmonella serovars 4,[5],12:i:-, Typhimurium, and Derby in animal 
study #2. The mean and standard error are represented by the horizontal and vertical lines, 
respectively. Statistically significant differences (p<0.05) were determined within each group 
compared to DPI 0 at which time no Salmonella was detectable. Significant differences were as 
follows: S. 4,[5],12:i:- on DPI 2, 4, and 7; S. Derby on DPI 2, 4, and 7; S. Typhimurium on DPI 
2, 4, 7, and 14.  
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Figure 8A.  
 
 
Figure 8B.  
Figure 8. Representative gross lesions following infection with Salmonella 4,[5],12:i:- and 
Salmonella Typhimurium. Spiral colon. (7A) Pig inoculated with Salmonella 4,[5],12:i:-, DPI 
4, severe diffuse fibrinous exudate. (7B) pig inoculated with Salmonella Typhimurium, DPI 4, 
severe diffuse fibrinous exudate. 
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Figure 9A.  
Figure 9. Comparison of histologic lesion scores from pigs inoculated with Salmonella 
serovars 4,[5],12:i:-, Typhimurium, and Derby and non-inoculated control pigs in animal 
study #2. Histologic lesion scores represent a summary of the ulceration, neutrophil infiltration, 
crypt elongation and abscessation, and submucosal inflammation at the time of necropsy on (9A) 
DPI 2, (9B) DPI 4, and (9C) DPI 28. Mean and standard error are represented by the symbols 
and vertical lines, respectively. Different letters indicate statistically significant differences 
between serovar groups, separated by tissue location (p<0.05). 
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Figure 9B. (continued) 
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Figure 9C. (continued) 
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Figure 10. Quantitative fecal culture results from animal study #3 in which pigs were 
simultaneously co-inoculated with equal amounts of two serovars of Salmonella: 4,[5],12:i:- 
and Typhimurium. The mean and standard error are represented by the horizontal and vertical 
lines, respectively. Asterisks represent days in which the mean amount of S. 4,[5],12:i:- was 
significantly different from the mean amount of S. Typhimurium (p<0.05). 
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Figure 11. Quantitative culture results from samples collected upon necropsy in animal 
study #3 in which pigs were simultaneously co-inoculated with equal amounts of two 
serovars of Salmonella: 4,[5],12:i:- and Typhimurium. The mean and standard error are 
represented by the horizontal and vertical lines, respectively. 
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Figure 12A. 
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Figure 12B.  
Figure 12. The competition index calculated based on the culture results from animal study 
#3. The competition index (CI) was calculated for (12A) fecal samples collected throughout the 
study period and (12B) samples collected at the time of necropsy on DPI 4 and 10. The CI 
represents the fitness of Salmonella 4,[5],12:i:- relative to Salmonella Typhimurium, with a 
positive CI indicating that S. 4,[5],12:i:- is more fit within the host and a negative CI indicating 
that S. Typhimurium is more fit within the host. Values closer to 1 or -1 indicates that 4,[5],12:i:- 
or Typhimurium were the dominant Salmonella serovar in that set of samples, respectively.  
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CHAPTER 4: 
SUMMARY AND FUTURE DIRECTIONS 
 
The objective for this thesis was to gain a better understanding of the increasing 
prevalence of S. 4,[5],12:i:-, to validate a more rapid testing method for Salmonella, to evaluate 
the disease, persistence, and colonization induced by Salmonella 4,[5],12:i:- within the swine 
host, and finally to compare the in vivo fitness of S. 4,[5],12:i:- relative to S. Typhimurium. 
Salmonella 4,[5],12:i:- has increased rapidly in prevalence in swine samples submitted to the 
Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL) since 2011. In conjunction 
with the increase in S. 4,[5],12:i:-, there has been a substantial decrease in prevalence of S. 
Typhimurium and other serovars within Salmonella serogroup B. To enable rapid detection of 
Salmonella species from swine samples, a multiplex real-time PCR was validated for the ISU-
VDL. This PCR is also able to differentiate S. 4,[5],12:i:- and S. Typhimurium, likely pathogens 
of swine, from other serovars considered to be of lesser pathogenicity. Additionally, use of the 
PCR facilitates identification at the serovar-level within 1-2 days of sample submission, rather 
than the 3-6 weeks expected with standard culture and serotyping.  
To improve the understanding of S. 4,[5],12:i:- as a pathogen of swine, pigs were infected 
with S. 4,[5],12:i:-, S. Typhimurium, or S. Derby to allow comparison of the recently emerging 
serovar to better known serovars. Salmonella 4,[5],12:i:- is able to induce similar levels of fever, 
diarrhea, and gross and histologic lesions as S. Typhimurium and more severe than that of S. 
Derby. Additionally, all three serovars were able to colonize tissues throughout the pig and 
persist for at least 28 days following infection. In an effort to better understand the cause of 
emergence of S. 4,[5],12:i:- over the past decade, pigs were simultaneously infected with equal 
amounts of S. 4,[5],12:i:- and S. Typhimurium. From this, it was determined that S. 4,[5],12:i:- 
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may possess a greater fitness level in vivo compared to S. Typhimurium, evidenced by higher 
amounts of S. 4,[5],12:i:- recovered from fecal and tissue samples.  
Although the work completed here provides a better understanding of the monophasic 
variant of S. Typhimurium, Salmonella 4,[5],12:i:-, additional research is needed. During 
validation of the rt-PCR, the cause of unexpected results of the fljB gene were not able to be fully 
explored. Future research to understand the cause of these unexpected results as well as 
improved characterization of S. 4,[5],12:i:- isolates from swine from the Midwestern United 
States through whole genome sequencing or other methods of analysis may aid in understanding 
the cause of emergence of the monophasic variant. Additionally, only one potential mechanism 
to explain the emergence of S. 4,[5],12:i:- was explored in this study, which was the potential 
increased competitive fitness relative to S. Typhimurium within the host. This competitive fitness 
work should be repeated with multiple S. 4,[5],12:i:- and S. Typhimurium isolates to ensure that 
the competitive fitness of S. 4,[5],12:i:- observed remains consistent across other isolates. Many 
other potential explanations for its emergence are plausible and also warrant future work; these 
include increased survival in the environment, increased ability to be transmitted, increased 
antimicrobial resistance, and increased heavy metal resistance. With a better understanding of the 
cause of emergence and characteristics of Salmonella 4,[5],12:i:- infections in swine, further 
work is warranted on appropriate and effective control and prevention strategies. One of the 
necessary components should focus on currently available vaccines for S. Typhimurium and the 
potential cross protection provided by these vaccines against S. 4,[5],12:i:-. 
